The QualityStocks Daily Stock List
- Omagine, Inc. (OMAG)
- Dakota Territory Resource Corp. (DTRC)
- Envision Solar International, Inc. (EVSI)
- MassRoots, Inc. (MSRT)
- Novo Integrated Sciences, Inc. (NVOS)
- Midwest Energy Emissions Corp. (MEEC)
- Research Solutions, Inc. (RSSS)
- ProMIS Neurosciences, Inc. (ARFXF)
- IronClad Encryption Corporation (IRNC)
- Leading Edge Materials Corp. (LEMIF)
- Copper Mountain Mining Corporation (CPPMF)
- Zinc One Resources, Inc. (ZZZOF)
- IntelGenx Technologies Corp. (IGXT)
- Bitcoin Investment Trust (GBTC)
- Torex Gold Resources, Inc. (TORXF)
Omagine, Inc. (OMAG)
SmallCapVoice, Information Solutions Group, Agoracom, BUYINS.NET, PennyStocks24, and OnTheMar reported earlier on Omagine, Inc. (OMAG), and we also highlight the Company, here at the QualityStocks Daily Newsletter.
Omagine, Inc. conducts all its real-estate development, tourism, and entertainment business activities through either its 60 percent owned subsidiary Omagine LLC or its 100 percent owned subsidiary Journey of Light, Inc. OTCQB-listed, Omagine’s concentration is on real-estate, entertainment, and hospitality opportunities in the Middle East and North Africa (MENA Region).
Incorporated in 2004, Omagine is based in New York, New York. It has a subsidiary in Muscat, Oman. The Company’s intention is to open branch offices in Beirut, Lebanon and in Dubai, The United Arab Emirates (UAE) during 2018.
Omagine announced in October 2014 that Omagine LLC signed a Development Agreement (DA) with the Government of the Sultanate of Oman. Omagine organized Omagine LLC under the laws of Oman to design, develop, own, and operate a tourism and real-estate development project in Oman named the Omagine Project.
Omagine LLC owns the Omagine Project. The other Omagine LLC shareholders are the office of Royal Court Affairs (RCA), which owns 25 percent, and two subsidiaries of Consolidated Contractors International Company, SAL (CCIC), which jointly own 15 percent.
As well as the Omagine Project in Oman, the Company has been having discussions with Omani government officials regarding other projects in Oman. Omagine has held initial discussions with government officials and business people in the MENA region concerning comparable projects and other business opportunities there.
Omagine announced in July of 2016 that its subsidiary, Omagine LLC, signed and registered with the Government of Oman, a Usufruct Agreement (UA), which legally perfects Omagine's ownership of the development rights (the Usufruct Rights) over 245 acres of beachfront land in the Sultanate of Oman.
The Omagine Project will be a union of cultural, heritage, educational, entertainment, and residential components. This includes a high culture theme park containing seven pearl shaped buildings, associated exhibition buildings, a boardwalk, an open-air amphitheater and stage, and open space green areas.
Additionally, the Project includes commercial office buildings, shopping and retail establishments integrated with the hotels, and around 2000 residences to undergo development for sale. Moreover, it includes a canal and an enclosed harbor and marina area, associated retail shops and restaurants, entertainment venues, boat slips, and docking facilities. It also includes a five-star resort hotel, a four-star resort hotel, and conceivably a three or four-star hotel.
Currently, Omagine focuses most of its efforts on the business of Omagine LLC and particularly on the Omagine Project. The Omagine Project is a mixed-use tourism and residential real estate project. The expectation is that it will take roughly five years from the start date to complete.
Omagine, Inc. (OMAG), closed Tuesday's trading session at $0.0111, up 0.91%, on 11,000 volume with 2 trades. The average volume for the last 3 months is 7,851 and the stock's 52-week low/high is $0.009/$0.175.
Dakota Territory Resource Corp. (DTRC)
OTC Markets Group, Innovative Marketing, and UltimatePennyStock reported earlier on Dakota Territory Resource Corp. (DTRC), and we are reporting on the Company today, here at the QualityStocks Daily Newsletter.
Dakota Territory Resource Corp.’s emphasis is on the acquisition and responsible exploration and development of high caliber gold properties in the Black Hills of South Dakota. The Company maintains 100 percent ownership of three mineral properties. These include the Blind Gold, City Creek, and Homestake Paleoplacer Properties. All of these are in the heart of the Homestake District. Dakota Territory Resource is based in Reno, Nevada and the Company lists on the OTC Markets.
The Blind Gold Property is Dakota’s flagship property. It is a target for Tertiary-aged and Iron-formation gold mineralization. The Blind Gold Property is around four miles northwest and on structural trend with the historic Homestake Gold Mine. The Homestake Gold Mine produced roughly 40 million ounces of gold through its 125-year production history. It is the largest iron-formation-hosted gold deposit in the world.
In March of last year, Dakota Territory Resource announced that its intention is to continue its sampling program along trend of the zone of high grade gold mineralization identified by the first pass surface sampling program conducted on its 100 percent owned Blind Gold Property. The program identified a zone of high-grade gold mineralization in the Mississippian-age Pahasapa Limestone on the surface, with a peak gold assay value of 9.44 grams per tonne. The Company is preparing for drilling in the Homestake Gold District of South Dakota.
Its City Creek Property is a target for Homestake iron-formation gold mineralization. City Creek consists of 21 unpatented lode mining claims located one-mile northeast of the Homestake Open Cut and one-mile northwest of the City of Deadwood.
The Homestake Paleoplacer Property consists of 13 unpatented lode mining claims positioned one-mile north of the Homestake Open Cut. Dakota Territory Resource based the acquisition of its Black Hills property position on more than 44 years of combined mining and exploration experience in the Homestake District.
This past April, Dakota Territory Resource announced that it entered into agreements with Trucano Novelty, Inc. to acquire a combination of surface and mineral title to 284 acres located in the Homestake District of the Northern Black Hills of South Dakota. Dakota’s property acquisition is consistent with its business development strategy of expanding its high quality mining interests within the Homestake District. The Company now holds approximately 3,341 acres in the core of the district.
In May, Dakota Territory Resource announced that its research of historic data identified high grade gold mineralization under Dakota Territory's recently acquired property at Maitland. In the 1960's, Homestake Mining Company collared diamond drill hole # 6091A at the western fringe of the Maitland Mine and drilled at a -50-degree angle to the southwest across Dakota Territory's recent land acquisition.
The hole was drilled to a total depth of 137.5 meters. This includes an 11.3-meter-long intercept from 111.2 meters to 122.5 meters down hole containing 5.18 grams per tonne gold. The gold intercept in diamond drill hole #6091A was in the Precambrian Poorman - Homestake - Ellison stratigraphic sequence, which hosted the 40 million-ounce Homestake gold deposit situated just over 4 km to the south.
Dakota Territory Resource Corp. (DTRC), closed Tuesday's trading session at $0.055, up 17.02%, on 100 volume with 1 trade. The average volume for the last 3 months is 20,330 and the stock's 52-week low/high is $0.0251/$0.098.
Envision Solar International, Inc. (EVSI)
Dividend Investor, Hotstocked, Greenbackers, Emerging Growth, RedChip, OTC Journal, FeedBlitz, SmarTrend Newsletters, 4-Traders, Stock News Now, SmallCapVoice, Stockopedia, Stockwire, and TradingView reported previously on Envision Solar International, Inc. (EVSI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.
Envision Solar International, Inc. is the leading renewably energized EV charging, outdoor media, and energy security products enterprise. The Company is a developer of solar products and proprietary technology solutions. It designs, manufactures, and deploys unique, renewably energized, EV charging and media and branding systems. OTCQB-listed, Envision Solar International is based in San Diego, California.
The Company’s products include the patented EV ARC™ and Solar Tree® product lines. All of its products can be enhanced with EnvisionTrak™ patented solar tracking, ARC Technology™ energy storage, SunCharge™ Electric Vehicle Charging Stations, and digital advertising packages.
Envision Solar has designed and incorporated EnvisionTrak, its proprietary and patented tracking solution, to the Solar Tree structure. It has deployed its latest generation of Solar Tree products, the Solar Tree HVLC (High Value, Low Cost) collection.
The new Solar Tree product incorporates the Company’s latest engineering and fabrication improvements. The Solar Tree® structure works as a billboard for a company’s green credentials. This is while producing clean energy and improving the aesthetics of any parking lot.
Additionally, Envision Solar has developed the above-mentioned EV ARC™. It has observed that the EV ARC™ (Electric Vehicle Autonomous Renewable Charger) can solve numerous problems associated with electric vehicle charging infrastructure deployments. The EV ARC™ fits inside a parking space. It produces enough clean solar electricity to power up to 225 miles of EV driving in a day.
This past November, Envision Solar International released financial results for Q3 and year to date, 2018. In Q3 2018, the Company achieved revenue of $938,218. This represents a 316 percent increase over the same period in 2017 and the highest Q3 revenue in the Company’s history.
Q3 gross profits increased by 574 percent over the same period in 2017. Envision Solar achieved YTD revenues of $4.7M. This represents a 322 percent increase over 2017 and higher than any full year in the Company’s history. YTD gross profits increased 470 percent over the same period in 2017. Revenue was attained through new and repeat customer orders of Envision Solar’s EV ARC™ products from government and enterprise customers.
Recently, Envision Solar International announced that Summit Credit Union chose the Company’s EV ARC™ products to provide emissions-free EV charging for employees at Summit Credit Union Headquarters in Wisconsin. Invented and manufactured in the State of California, the patented EV ARC™ and EV ARC™ HP products fit inside single parking spaces without reducing available parking.
Envision Solar International, Inc. (EVSI), closed Tuesday's trading session at $0.1925, down 1.28%, on 32,185 volume with 10 trades. The average volume for the last 3 months is 42,872 and the stock's 52-week low/high is $0.145/$0.429.
MassRoots, Inc. (MSRT)
Stock News Now, OTCtipReporter, PennyStockScholar, Profitable Trader Authority, SmallCapVoice, Penny Stock 101, CFN Media Group, Wealth Daily, Cannabis Financial Network News, Promotion Stock Secrets, Stock Commander, Damn Good Penny Picks, Penny Picks, OTCJournal, and StockRockandRoll reported earlier on MassRoots, Inc. (MSRT), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
MassRoots, Inc. is a leading technology and rewards platform for medical cannabis patients and businesses. Individuals use its application to share their cannabis experiences and stay connected with local dispensaries. MassRoots has affiliations with the top organizations in the cannabis industry. MassRoots lists on the OTC Markets Group’s OTCQB.
MassRoots’ product pipeline includes Dispensary Finder & Menus; Product Pages & Reviews; Sponsored Posts 2.0; and Enhanced Profiles. The majority of the Company’s advertising revenue has come from dispensaries and cannabis-brands in the States of California and Colorado.
Businesses can use MassRoots to advertise their goods and services to cannabis consumers. MassRoots starts adding in features. These include order ahead, delivery, and the in-app purchase of ancillary products as regulations allow.
In January of 2017, MassRoots acquired DDDigtal, d.b.a. "Whaxy”. This is an online order-ahead and menu management platform. MassRoots has made a strategic investment in High Times Holding Corporation, "High Times", the leading voice of the Cannabis Industry.
MassRoots also acquired Odava, Inc. MassRoots now offers dispensaries a complete set of software to manage their regulatory compliance, streamline their supply chain, and develop successful consumer loyalty programs. Odava is a foremost compliance and point-of-sale (POS) system for the cannabis industry.
Furthermore, MassRoots acquired CannaRegs, Inc. CannaRegs is a top technology platform. It tracks changes in cannabis regulations and taxation at the municipal, state, and federal levels. Moreover, MassRoots created MassRoots Blockchain Technologies, Inc. This is a wholly-owned subsidiary of MassRoots committed to developing blockchain-based solutions for the cannabis industry.
In late December, MassRoots announced that its WeedPass™ rewards system has gained adoption by over 140 dispensary locations since launching in August of 2018. MassRoots is continuing to expand the diversity of rewards offered by WeedPass™ and the markets in which it's available. At present, the Company offers its WeedPass™ rewards program to regulated dispensaries in Denver and Los Angeles. It plans to expand to the San Francisco and Phoenix markets in early 2019. WeedPass™ enables consumers to earn tickets to movies, sporting events, as well as festivals by shopping at participating dispensaries.
MassRoots, Inc. (MSRT), closed Tuesday's trading session at $0.086, up 22.86%, on 1,931,636 volume with 288 trades. The average volume for the last 3 months is 836,646 and the stock's 52-week low/high is $0.046/$0.97.
Novo Integrated Sciences, Inc. (NVOS)
Stockwatch, OTC Markets, Stock Orange, Investor Place InvestorsHub, Corporate Information, Street Insider, Infront Analytics, Stockopedia, Simply Wall St, TradingView, Stockhouse, MarketWatch, Investing News Alerts, and Biospace reported previously on Novo Integrated Sciences, Inc. (NVOS), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Novo Integrated Sciences, Inc. is a provider of multi-disciplinary primary healthcare services and products in Canada through its wholly-owned Canadian subsidiary Novo Healthnet Limited (NHL). The Company’s mission is to build a U.S. and Canadian based multi-disciplinary primary healthcare service provider that provides first-class specialized healthcare services and products via the integration of technology and medical science. OTCQB-listed, Novo Integrated Sciences is headquartered in Bellevue, Washington.
Novo Healthnet Limited (NHL) owns a 100 percent stake in Novo Assessments, Inc., Novo Healthnet Rehab Limited, Novo Peak Health, Inc., and an 80 percent stake in Novo Healthnet Kemptville Centre, Inc. All of these are Province of Ontario companies.
Novo Healthnet Limited (NHL) - directly and indirectly, by way of its contractual relationships - provides its specialized services to over 400,000 patients annually. It does so through its 16 corporate-owned clinics and a contracted network of 92 affiliate clinics and 223 eldercare centric homes located across Canada.
The Novo Family's services include pain assessment, treatment, management, and prevention. These are provided in corporate owned clinics, homes, and institutional locations across Canada.
Novo Integrated Sciences’ multi-disciplinary primary healthcare services and protocols are directed at assessment, treatment, management, rehabilitation and prevention. The Novo Family provides specialized physiotherapy, chiropractic care, occupational therapy, eldercare, laser therapeutics, and massage therapy. Additionally, it provides acupuncture, chiropodist, neurological functions, kinesiology, certain dental assessments, certain long-term care services, and other para-medical services to its clients.
Recently, Novo Integrated Sciences and Novo Healthnet Limited (NHL) announced that on November 23, 2018, the Company and NHL executed a binding Letter of Intent (LOI) with Activa Clinics, a private Canadian company involved in the delivery of multi-disciplinary primary healthcare services and programs via its seven strategically located Southern Ontario clinics.
The LOI contemplates that the Company and NHL will enter into a share exchange agreement with Activa and the Activa shareholders. NHL will acquire 100 percent of Activa’s total share capital, non-dilutive. In exchange the Activa shareholders will be issued CAD $35,000,000 worth of restricted shares of the Company’s common stock.
In December, Novo Integrated Sciences and Novo Healthnet Limited (NHL) announced the signing of a definitive Share Exchange Agreement (SEA), dated December 18, 2018, with CannaPiece Group, Inc., an Ontario province corporation and a late stage applicant for issuance, from Health Canada, of a cannabis cultivation, extraction and sale license under the Access to Cannabis for Medical Purposes Regulations. Upon closing of the SEA, NHL will acquire a 25 percent stake in CannaPiece in exchange for delivery, by the Company to CannaPiece, of 20,296,196 Novo Integrated Sciences restricted common shares.
Novo Integrated Sciences, Inc. (NVOS), closed Tuesday's trading session at $1.96, down 0.76%, on 1,065 volume with 10 trades. The average volume for the last 3 months is 6,543 and the stock's 52-week low/high is $0.1135/$2.99.
Midwest Energy Emissions Corp. (MEEC)
SeriousTraders, MissionIR, Hotstocked, Otc.Watch, Marketbeat, Wall Street Resources, NBT Equities Research, Greenbackers, TopPennyStockMovers, and PennyStocks24 reported previously on Midwest Energy Emissions Corp. (MEEC), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter
Midwest Energy Emissions Corp. is an emerging leader in mercury emissions control technology for the global coal-power industry. The Company develops and utilizes patented and proprietary technologies to remove mercury from coal-power plant emissions. Midwest Energy Emissions concentrates on the delivery of mercury capture technologies to power plants and other industrial coal-burning units in North America, Europe, and Asia. The Company is based in Lewis Center, Ohio.
Midwest Energy Emissions utilizes patented technology that has been shown to attain mercury removal levels compliant with the U.S. Environmental Protection Agency's (EPA) Mercury and Air Toxic Standards (MATS) rule, at a considerably lower cost and with less operational impact than methods presently used. This is while preserving the ability for customers to recycle and sell fly-ash for beneficial use.
The Company’s proprietary SEA™ (Sorbent Enhancement Additive) technology delivers a flexible, tunable solution. It allows the international coal-power industry to easily comply with new, highly restrictive regulations on mercury air emissions. Midwest Energy Emissions acquired all patent rights for its Sorbent Enhancement Additive (SEA™) mercury emissions control technology from the Energy & Environmental Research Center Foundation (EERCF of Grand Forks, North Dakota).
This past November, Midwest Energy Emissions engaged Caldwell Cassady & Curry P.C., an IP law firm headquartered in Dallas, Texas, to lead the efforts to license the Company’s SEA® technologies throughout the USA coal fleet. SEA® technologies, the enhancing of a sorbent with a halide-based substance, have been adopted by a substantial number of utility operations across the United States. Midwest Energy Emissions is offering licenses and other commercial options to the users of these patented technologies, including the Company’s specialized expertise.
Today, Midwest Energy Emissions announced that it appointed Marcum LLP as its new independent registered public accounting firm, effective immediately. Marcum is one of the largest independent public accounting and advisory services firms in the nation. It is ranked 16th nationally. Marcum offers the resources of 1,800 professionals, including more than 240 partners, in 35 offices across the United States, Grand Cayman and China.
Midwest Energy Emissions Corp. (MEEC), closed Tuesday's trading session at $0.25, down 1.96%, on 30,000 volume with 4 trades. The average volume for the last 3 months is 28,056 and the stock's 52-week low/high is $0.11625/$0.469.
Research Solutions, Inc. (RSSS)
Marketbeat.com and Wall Street Resources reported earlier on Research Solutions, Inc. (RSSS), and we also report on the Company, here at the QualityStocks Daily Newsletter.
OTCQB-listed, Research Solutions, Inc. is an innovator in providing cloud-based solutions for scientific research. The Company is a pioneer in cloud-based SaaS (Software-as-a-Service) research intelligence products and services for research-intensive organizations. Research Solutions has its wholly-owned subsidiary Reprints Desk, Inc. The Company’s cloud-based SaaS platform provides customers with on demand access to, and augmented data from, tens of millions of scientific, medical, and technical (STM) documents. This is in addition to tens of millions of articles beforehand published. Research Solutions has its corporate headquarters in Encino, California.
Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions, medical affairs, and scientific, technical, and medical (STM) research. Reprints Desk and Altmetric LLP previously agreed to integrate Altmetric badges to scholarly content obtained via Reprints Desk's award-winning research retrieval platform Article Galaxy. Altmetric is a top research metrics provider.
The Altmetric badges provide an at-a-glance visualization of the attention a particular journal article has received online from mainstream and social media, public policy documents, blogs, Wikipedia, and scholarly forums. These help scientists in assessing the reach and influence of research.
Research Solutions and its wholly-owned subsidiary Reprints Desk have launched a new version of the Company's award-winning Article Galaxy research platform. New features include full mobile responsiveness, design enhancements, an improved order history page, and the introduction of an ecosystem of gadgets - robust applications that allow for sophisticated data augmentation of content.
Reprints Desk has signed separate reseller agreements with Ritme and Alfasoft to deliver new tools and services that address the complete range of knowledge acquisition and information management requirements of researchers in scientific, technical, and also medical (STM) fields.
In May, Research Solutions reported financial results for its fiscal Q3 ended March 31, 2017. Total revenue was $8.6 million versus $8.7 million in the year-ago quarter. Platform revenue was up 124 percent to $270,920, with a 152 percent increase in total Platform deployments to 116. Annual recurring revenue was up 127 percent to $1.1 million.
Customer count was up 9 percent to 985. Transaction count was up 7 percent to 212,827. Transaction revenue was basically unchanged at $6.4 million. Net loss was $(0.6) million, or $(0.03) per share, versus net income of $32,000 or $0.00 per share. This loss was because of Research Solutions’ continued investment in its rapidly growing, recurring revenue Platform business.
Recently, Outsell, Inc. gave Research Solutions and Reprints Desk top ratings for its recently released version of the Article Galaxy SaaS research platform. Outsell is the globe’s only research and advisory firm centered on media, information, and technology. The Outsell Insights published on April 21, 2017 concludes that Reprints Desk is delivering a considerably improved service to researchers, which provides an enhanced user experience and creates efficiencies within end-user workflows focused around app-like gadgets.
Research Solutions, Inc. (RSSS), closed Tuesday's trading session at $2.40, up 6.67%, on 400 volume with 2 trades. The average volume for the last 3 months is 5,354 and the stock's 52-week low/high is $1.05/$2.70.
ProMIS Neurosciences, Inc. (ARFXF)
Penny Stock Hub, 4-Traders, Streetwise Reports, Stockhouse, TradingView, Investopedia, Wallmine, Insider Financial, Uptick Newswire, Capital Cube, InvestorsHub, MarketWatch, OTC Markets, and Dividend Investor reported earlier on ProMIS Neurosciences, Inc. (ARFXF), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
ProMIS Neurosciences, Inc. centers on discovering and developing precision medicine therapeutics to treat neurodegenerative diseases, in particular Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD). ProMIS Neurosciences’ lead product is PMN310 in Alzheimer’s disease. OTCQB-listed, ProMIS Neurosciences has offices in Toronto, Ontario and Cambridge, Massachusetts.
ProMIS’ proprietary target discovery engine is based on the use of two complementary techniques. ProMIS applies its thermodynamic, computational discovery platform-ProMIS™and Collective Coordinates - to predict novel targets known as Disease Specific Epitopes (DSEs) on the molecular surface of misfolded proteins. Using this innovative precision medicine approach, the Company is developing novel antibody therapeutics and specific companion diagnostics for AD and ALS.
ProMIS Neurosciences uses its proprietary technology platform to create highly selective antibodies. The Company’s lead programs are following a “best in class” strategy targeting Amyloid beta in Alzheimer’s disease, with advantages over ”first in class” therapy from Biogen (aducanumab).
ProMIS’ PMN310 is on course to further confirm differentiation from likely “first in class” Biogen’s aducanumab. In addition, PMN310 is on course to initiate clinical trials this year and potentially superior clinical data in comparison to aducanumab in late 2021 shortly after aducanumab anticipated approval.
For Alzheimer’s disease, ProMIS Neurosciences’ most advanced priority program, three validated product candidates have been designated. These are PMN310, PMN350, and PMN330. The Company announced in January 2018 that its lead product candidate for Alzheimer's disease (AD), PMN310, showed absence of binding to amyloid beta (Aβ) plaque in and around blood vessels in AD brain samples in a preclinical study directly comparing PMN310 to other Aβ-directed antibodies.
At the end of October 2018, ProMIS Neurosciences announced the identification of novel targets on misfolded, pathological forms of tau. The Company said that the development of antibody therapeutics, which selectively block these toxic forms of tau constitutes an exciting approach to treating Alzheimer's and other neurodegenerative diseases.
Over the course of 2018, ProMIS Neurosciences made major progress in expanding its portfolio of opportunities across numerous neurodegenerative diseases. Dr. Elliot Goldstein, ProMIS President and Chief Executive Officer, said, "Based on interactions with potential pharmaceutical partners, we believe our proprietary discovery platform and the resulting expanded portfolio offer real partnering opportunities. Antibody therapeutics targeting toxic forms of tau, TDP43 and, especially alpha-synuclein, are high on the list of partnering objectives for many companies in the field. We are actively pursuing partnering discussions for our developing portfolio as we continue to generate data in support of these programs."
ProMIS Neurosciences, Inc. (ARFXF), closed Tuesday's trading session at $0.22, up 7.00%, on 73,553 volume with 29 trades. The average volume for the last 3 months is 87,003 and the stock's 52-week low/high is $0.138/$0.589.
IronClad Encryption Corporation (IRNC)
4-Traders, PennyStockHub, The Street, Simply Wall St, MarketWatch, InvestorsHub, OTC Markets, YCharts, Barchart, Investors Hangout, Stock News Now and TradingView reported earlier on IronClad Encryption Corporation (IRNC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
IronClad Encryption Corporation is a next-generation cyber defense company headquartered in Houston, Texas. Its strategic and tactical data protection solutions strengthen existing encryption methods. The Company’s technology can provide continuous authentication of encrypted data transmitted, creating much stronger defenses to most hacker attacks. IronClad Encryption lists on the OTC Markets’ OTCQB.
IronClad Encryption-powered solutions use the Company’s patented Dynamic Encryption and Perpetual Authentication technologies to make all known key-based encryption technologies almost impossible to compromise. Dynamic Encryption Technology eliminates vulnerabilities caused by exposure of any single encryption key through continually changing encryption keys and keeping the keys synchronized in a fault-tolerant way.
Dynamic Encryption technology eliminates the single point of failure problem inherent in single-key encryption techniques. IronClad’s key management system continuously produces synchronous keys between the sender and receiver. Each key is assigned to a small amount of data. Therefore, if a hacker were to access one of hundreds of millions of keys, the amount of data he would obtain would be almost useless.
IronClad Encryption has a partnership with Black Pearl Engineering Management, Inc. to co-develop ultra-secure products based on IronClad’s patented ultra-secure cybersecurity algorithms and methodologies. The joint venture (JV) operates under the name "Black ICE". It is initially focusing on network gateway products. BlackICE Barrier is the first product in a family of BlackICE products. BlackICE Barrier is specifically targeted at enterprises and industrial use cases where data and control systems require the highest level of security.
IronClad Encryption offers its ICEMicro. This is the world’s first context-free and natively-secure container. It enables all developers to take ownership of application data security. Employing ICEMicro, any developer can secure communication between containers across varied scheduling and orchestration platforms, IaaS services, transport-layer security protocols, and on-premises or hybrid environments utilizing Docker-compatible hypervisors.
Recently, IronClad Encryption announced that it received notice from the United States Patent and Trademark Office (USPTO) that six of its patents were allowed. The titles of the IronClad patents that have been provided a Notice of Allowance include: Securitization of Temporal Digital Communications with Authentication and Validation of User and Access Devices; User-Wearable Secured Devices Provided Assuring Authentication and Validation of Data Storage and Transmission; and Devices that Utilize Random Tokens Which Direct Dynamic Random Access.
Titles also include: Devices for Transmitting and Communicating Randomized Encrypted Data Utilizing Sub-Channels; Executable Coded Cipher Keys; and Combined Hidden Dynamic Random-Access Devices Utilizing Selectable Keys and Key Locators for Communicating Randomized Data together with Sub-Channels and Coded Encryption Keys.
IronClad Encryption Corporation (IRNC), closed Tuesday's trading session at $0.20, even for the day. The average volume for the last 3 months is 6,440 and the stock's 52-week low/high is $0.05/$4.99.
Leading Edge Materials Corp. (LEMIF)
Penny Stock Tweets, Wall Street Analyzer, InvestorsHub, MarketWatch, Stockhouse, Metals Channel, 4-Traders, Investing News, Metals News, Market Screener, and Investor Place reported previously on Leading Edge Materials Corp. (LEMIF), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.
Leading Edge Materials Corp. focuses on the production of high value critical raw materials for the European market. The Company has an operating base in the Nordic region. Its flagship asset is the Woxna Graphite production facility located in central Sweden targeting the supply of specialty materials for lithium ion battery production. Leading Edge Materials has its corporate headquarters in Vancouver, British Columbia. The Company lists on the OTC Markets Group’s OTCQB.
Leading Edge Materials operates in four divisions. These are Graphite, Lithium, Rare Earth and Cobalt. The Company's assets and research emphasis are towards the raw materials for Li-ion batteries (graphite, lithium, cobalt); materials for high thermal efficiency building products (graphite, silica, nepheline); and materials that improve the efficiency of energy generation (dysprosium, neodymium, hafnium). Its investments are linked to the worldwide shift to low-carbon energy generation and energy storage.
Leading Edge Materials has 100 percent ownership of industry-leading assets in the Nordic region. The Company has 100 percent ownership of graphite, cobalt, lithium and rare earth element deposits across three mining supportive jurisdictions. Leading Edge Materials also has a unique position in the sustainable supply of critical materials for the high growth lithium ion battery market.
In October 2018, Leading Edge Materials reported the signing of a non-binding Letter of Intent (LOI) with private Swedish company Graphmatech AB. The LOI defines a pathway to create a binding Joint Venture between the companies to produce graphene at Leading Edge Material's Woxna graphite mine. Graphmatech has developed Aros Graphene®, which prevents the agglomeration of graphene flakes.
Recently, Leading Edge Materials provided an update concerning the progress of its Romanian Exploration Alliance. The Exploration Alliance is centered on the discovery and development of lithium ion battery raw materials. The main efforts of the Exploration Alliance to date (as of November 6, 2018) has been directed towards cobalt mineralization within the Upper Cretaceous Carpathian magmatic belt of the Balkan region. Blair Way, President and Chief Executive Officer, stated "Our Exploration Alliance in Romania is making good progress, with an experienced team in place and work underway on a number of high potential cobalt prospects. We look forward to sharing project details as we progress to an Exploration License application".
Yesterday, Leading Edge Materials announced the start of a formal internal corporate strategic review, led by Chairman of the Company Mr. Michael Hudson and Mr. Filip Kozlowski , an independent director of the Company. The Board of Directors of Leading Edge Materials received feedback from shareholders that the present trading price of its common shares does not adequately reflect the underlying value of the Company and its portfolio of individual assets. The Company’s Board shares this view. It has initiated a Strategic Review to identify, examine and consider all potential opportunities towards enhancing shareholder value and enable the Company to fast-track customer engagement in the fast developing European battery materials industry.
Leading Edge Materials Corp. (LEMIF), closed Tuesday's trading session at $0.1516, down 6.29%, on 14,700 volume with 4 trades. The average volume for the last 3 months is 69,119 and the stock's 52-week low/high is $0.1085/$0.80.
Copper Mountain Mining Corporation (CPPMF)
OTC Markets, Stockhouse, 4-Traders, Silicon King, InvestorsHub, Barron’s, YCharts, CapitalCube, Morningstar, PennyStockTweets, TradeKing, and Barchart reported earlier on Copper Mountain Mining Corporation (CPPMF), and today we report on the Company, here at the QualityStocks Daily Newsletter.
Copper Mountain Mining Corporation is a mining enterprise based in Vancouver, British Columbia. The Company’s flagship asset is the Copper Mountain mine positioned in southern British Columbia, near the town of Princeton. The mine is around 20 km south of Princeton and 300 km east of the port of Vancouver. The Copper Mountain mineral claims comprise roughly 18,000 acres (greater than 28 square miles; 73 square km). Copper Mountain Mining lists on the OTC Markets.
The Company has a strategic alliance with Mitsubishi Materials Corporation. Mitsubishi Materials owns 25 percent of the Copper Mountain mine. The Copper Mountain mine produces approximately 100 million pounds of copper equivalent production annually. This includes major gold and silver credits. All are shipped to Japan for smelting in one of Mitsubishi Materials’ copper smelters.
The Copper Mountain mine (based on the 2015 AIF disclosure) has an expected mine life of 17 years. Resources include 5 Billion lbs of Cu with precious metal credits. Secondary metals include gold, silver - about 20 percent of Revenue. This mine is a conventional open pit, truck and shovel operation.
The Company has its Fenton project. The Fenton Property is 33 km south of Houston, British Columbia. Fenton is an advanced stage polymetallic exploration project with considerable potential. Copper Mountain Mining has had the property under option since 2012. It has advanced this project through mapping, soil geochemistry, ground and airborne geophysics, as well as percussion and diamond drilling.
At the beginning of October, Copper Mountain Mining announced positive results from its Feasibility Study on its 100 percent owned Eva Copper Project in Queensland, Australia. Copper Mountain Mining's President and Chief Executive Officer, Gil Clausen, said, "The results of the Eva Feasibility Study clearly demonstrate the quality and size of this asset. Eva has the potential to add significant cashflow to our operating base, at one of the lowest capital intensities for near-term greenfield projects anywhere, in the best mining jurisdiction in the world."
Also this month, Copper Mountain Mining announced Q3 2018 production results for its Copper Mountain Mine in southern British Columbia. All results are reported on a 100 percent basis. Production for Q3 2018 was 18.3 million pounds of copper, 7,500 ounces of gold and 64,900 ounces of silver, which was in line with expectations.
Copper Mountain Mining guided that Q3 2018 copper production would be roughly 10 percent lower than Q2 because of lower copper grades being mined. Actual copper production was 8.5 percent lower than Q2. The expectation is that Q4 copper production will be the strongest quarter of 2018. The Company remains on course to attain 2018 annual production guidance of 80 million pounds of copper (+/-5 percent).
Copper equivalent production was 22.0 million pounds. It was down only 4.8 percent versus Q2 because of higher gold production as a result of increased gold grade and recovery after the installation of a flash flotation circuit in the concentrator.
Copper Mountain Mining Corporation (CPPMF), closed Tuesday's trading session at $0.65, up 6.56%, on 18,540 volume with 6 trades. The average volume for the last 3 months is 25,133 and the stock's 52-week low/high is $0.48/$1.29.
Zinc One Resources, Inc. (ZZZOF)
NetworkNewsWire, 4-Traders, MarketWatch, YCharts, InvestorX, Market Screener, Wall Street Profiler, Streetwise Reports, InvestorIntel, Stock of the Week, Investing News, Barchart, StockInvest.us, Epic Stock Picks, All Penny Stocks, Dividend Investor, Insider Financial, Marketwired, Wallet Investor, Investor Ideas, Investors Hangout, InvestorsHub, and Stockhouse reported on Zinc One Resources, Inc. (ZZZOF), and today we choose to report on the Company, here at the QualityStocks Daily Newsletter.
Zinc One Resources, Inc. concentrates on the acquisition, exploration and development of prospective and advanced zinc projects in mining-friendly jurisdictions. Its key assets are the past producing Bongará Zinc Mine Project and the Charlotte-Bongará Zinc Project in Peru. The Company formerly went by the name Rockridge Capital Corp. It changed its corporate name to Zinc One Resources, Inc. in January 2017. Zinc One Resources is based in Vancouver, British Columbia. The Company lists on the OTC Markets.
Zinc One Resources acquired Forrester Metals, Inc. in June 2017. Accordingly, it acquired the Bongará Mine and Charlotte-Bongará Projects. Both host high-grade, nonsulphide zinc mineralization at or near the surface. At the Bongará Zinc Mine the mineralization is concentrated along and proximal to a NW – trending anticlinal axis over approximately 2.5 kilometers.
The Bongará Zinc Mine was mined in 2007 and 2008 by a former owner by open-pit methods, dried at the site, and then shipped 540 kilometers westward to the coast where it was processed through a Waelz kiln. This is a processing technology typically applied to flue dust from steel mills to recover zinc. In August of 2008, the mine was closed down mainly due to a drop in the price of zinc at that time.
The exploration upside at Charlotte-Bongará includes greater than 8,000 meters of drilling. This includes results of 29.5% Zn across 15.5 meters, 26.1% Zn across 12.5 meters, as well as 29.7% Zn across 11.5 meters.
Last week, Zinc One Resources announced additional drill results from the remaining holes in the Mina Grande Norte zone, Bongará Zinc Mine project situated in north-central Peru. High-grade intercepts included up to 39.6 meters of 37.0% zinc from MGN18010 and 14.4 meters of 40.5% zinc from MGN18012.
The drill program at Mina Grande Norte encountered manifold high-grade intercepts in the western sector and, along with the results from pit sampling, establish that the mineralization encompasses an area of roughly 175 meters in an east-west direction and 100 meters in a north-south direction. Mina Grande Norte is a part of one of the three zones of high-grade, near-surface zinc-oxide mineralization along a 1.4 kilometer mineralized trend, which was tested by this drill program that comprised 264 holes for 7,931 meters.
Today, Zinc One Resources announced that it appointed Dr. Bill Williams, COO and a Director of Zinc One, as the interim Chief Executive Officer (CEO) effective November 13, 2018. Mr. James Walchuck has been the CEO and a Director of Zinc One and he remains a consultant to the Company.
Zinc One Resources, Inc. (ZZZOF), closed Tuesday's trading session at $0.0695, up 21.72%, on 7,000 volume with 2 trades. The average volume for the last 3 months is 36,364 and the stock's 52-week low/high is $0.0438/$0.4499.
IntelGenx Technologies Corp. (IGXT)
Streetwise Reports, StockInvest, MarketWatch, Stockhouse, GuruFocus, YCharts, Wolf Street, Market Screener, last10k, InvestorsHub, Zacks, Morningstar, Wallet Investor, Real Investment Advice, and Equity Clock reported previously on IntelGenx Technologies Corp. (IGXT), and we also report on the Company, here at the QualityStocks Daily Newsletter.
IntelGenx Technologies Corp. is a leading oral drug delivery company based in Saint-Laurent, Quebec. It primarily concentrates on the development and manufacturing of innovative pharmaceutical oral films based on its proprietary VersaFilm™ technology platform. The Company’s state-of-the-art manufacturing facility, constructed for the VersaFilm™ technology platform, supports lab-scale to pilot and commercial-scale production, providing full service capabilities to its clients. IntelGenx Technologies lists on the OTC Markets Group’s OTCQX.
The VersaFilm™ and VetaFilm™ rapidly disintegrating thin polymeric film technologies improve drug performance. Moreover, they ease administration without the need for water. IntelGenx states that the VersaFilm™ and VetaFilm™ products have the potential to enhance bioavailability, hasten onset of action, decrease side effects and ease administration, therefore improving patients’ compliance and satisfaction.
IntelGenx Technologies’ highly skilled team provides extensive pharmaceuticals services to pharmaceutical partners. These services include research and development (R&D), analytical method development, clinical monitoring, IP and regulatory services. Additionally, the Company’s VetaFilm™ consists of R&D services for veterinary oral film technology.
This past September, IntelGenx Technologies announced that it executed a non-binding Letter of Intent (LOI) with Tilray, Inc. (TLRY) to co-develop and commercialize oral film products infused with recreational and medical cannabis (cannabis-infused VersaFilm™), in expectation of amended cannabis regulations that would allow adult-use consumers to purchase edible products. Tilray is a global leader in cannabis research, cultivation, production and distribution.
This month, IntelGenx announced the execution of a definitive license, development, and supply agreement with Tilray, Inc. With the Agreement, the two companies will co-develop and commercialize oral film products infused with adult-use and medical cannabis (cannabis-infused VersaFilm™”). Under the Agreement, IntelGenx and Tilray will each fund 20 percent and 80 percent of the costs associated with the development of the cannabis-infused Versafilm™ products, respectively.
Today, IntelGenx announced that patient dosing has begun in the Phase 2a study of Montelukast VersaFilm™ in patients with mild to moderate Alzheimer’s Disease (AD). The True North Clinical Research site in Kentville, Nova Scotia is the first of eight research sites in Canada to enroll a patient and start dosing. The randomized, double-blind, placebo controlled Phase 2a proof of concept study will enroll about 70 subjects with mild to moderate AD. The study will evaluate the safety, feasibility, tolerability, and efficacy of Montelukast buccal film following daily dosing for 26 weeks.
IntelGenx Technologies Corp. (IGXT), closed Tuesday's trading session at $0.538, down 0.37%, on 109,002 volume with 25 trades. The average volume for the last 3 months is 478,924 and the stock's 52-week low/high is $0.43/$1.83.
Bitcoin Investment Trust (GBTC)
Stock Twits, Zacks, CryptoCurrencyFacts, Stock Investor, Street Insider, Strategic Coin, Investopedia, Morningstar, MarketWatch, SlashGear, Stockhouse, Finance Registrar, TradingView, Bitcointalk, The Street, Business Insider, Investor Place, MintDice, Wallet Investor, Brave New Coin, and Cointelegraph reported on Bitcoin Investment Trust (GBTC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.
Grayscale Investments, LLC is an authority on digital currency investing. The Company provides secure access to the digital currency asset class by way of its single-asset and diversified investment products. These include Bitcoin Investment Trust™ (GBTC) and Digital Large Cap Fund™. Formed in 2013 by Digital Currency Group, Grayscale Investments is headquartered in New York, New York. The Company lists on the OTC Markets Group’s OTCQX.
Bitcoin Investment Trust™ is a privately offered trust. It is available solely to accredited investors. Bitcoin Investment Trust’s investment goal is for the value of its shares to reflect the price performance of bitcoin, minus fees and expenses. Bitcoin Investment Trust was established for investors looking for exposure to bitcoin via a traditional investment vehicle.
Bitcoin Cash Investment Trust™ is a privately offered trust. It is available exclusively to accredited investors. Bitcoin Cash Investment Trust’s investment goal is for the value of its shares to reflect the price performance of Bitcoin Cash (BCH), minus fees and expenses. Bitcoin Cash Investment Trust was established for investors looking for exposure to BCH through a traditional investment vehicle.
Last week, Grayscale Investments announced the launch of Zen Investment Trust. This is a single-asset investment vehicle solely consisting of ZEN, a privacy-focused digital currency.
Zen Investment Trust is the eighth single-asset investment product introduced by Grayscale. In addition, it is the first security solely invested in ZEN. Further to its single-asset products, Grayscale Investments also manages the above-mentioned Digital Large Cap Fund™. This is a diversified investment product, which provides exposure to the leading digital currencies by market capitalization.
ZEN is a privacy-oriented digital currency. It is native to Horizen (previously ZenCash), a decentralized technology platform that provides users with total control of their digital footprint.
Mr. Michael Sonnenshein, Managing Director of Grayscale Investments, said, "We've been very impressed with the Horizen team and its vision for ZEN as a leading privacy coin. Grayscale is at the forefront of asset management in this emerging industry, and we will continue to offer our clients access to the most interesting blockchain projects in the world."
Bitcoin Investment Trust (GBTC), closed Tuesday's trading session at $4.96, up 2.06%, on 2,653,204 volume with 2,713 trades. The average volume for the last 3 months is 2,115,528 and the stock's 52-week low/high is $3.76/$25.20.
Torex Gold Resources, Inc. (TORXF)
Hotstocked, Marketbeat, Mining Stock Valuator, Tip Ranks, Dividend Investor, Northern Miner, InvestorsHub, Resource World, Emerging Growth, Barchart, 4-Traders, Northern Vertex, The Assay, Penny Stock Tweets, World Trading Data, Stockhouse, Capital Cube, YCharts, Midas Letter, Wallet Investor, and Market Screener reported on Torex Gold Resources, Inc. (TORXF), and we report on the Company as well, here at the QualityStocks Daily Newsletter.
Torex Gold Resources, Inc. engages in the exploration, development, and operation of mineral properties. The Company explores for gold, silver, and copper deposits. An intermediate gold producer, it engages in the exploration, development and operation of its 100 percent owned Morelos Gold Property. This is an area of 29,000 hectares in the highly prospective Guerrero Gold Belt situated 180 kilometers southwest of Mexico City. Torex Gold Resources is headquartered in Toronto, Ontario.
The Company’s principal assets include the El Limón Guajes Mining Complex, comprising the El Limón, Guajes and El Limón Sur open pits, the El Limón Guajes underground mine including zones referred to as Sub-Sill, El Limón Deep, and the processing plant and related infrastructure, which commenced commercial production in April of 2016.
Additionally, Torex’s principal assets include the Media Luna Deposit, an early stage development project, and for which the Company issued a Preliminary Economic Assessment (PEA) in 2015. This property remains 75 percent unexplored.
El Limon-Guajes is Torex’s first Mine. The El Limon-Guajes Mine (ELG), positioned north of the Balsas River, constitutes one of the richest open pit gold deposits at a resource grade of 2.65 g/t. The Mine began gold production in December of 2015. On March 30, 2016, it announced commercial production. Upon being in full production, the Mine will be among the largest and lowest cost gold mines worldwide with expected LOM average annual production of 370,000 ounces of gold at a LOM AISC (All in Sustaining Cost) of US$616/oz.
The Media Luna deposit is hosted in a magnetic anomaly south of the Balsas River. It was discovered in March 2012. It has current Inferred Resources of 7.4 million gold equivalent ounces at a grade of 4.48 g/t.
The resource is contained in less than 30 percent of the area of the targeted magnetic anomalies. The conceptual design contained in a positive PEA (Preliminary Economic Assessment) announced in July of 2015 anticipates an underground operation with expected average annual production of 313,000 ounces of gold equivalent at an average AISC of US$636/oz.
Last month, Torex Gold Resources announced the results from 57 holes, from its in-fill and step-out drilling programs in the Sub-Sill Zone of its El Limón Guajes (ELG) Underground Mine in Southwest Mexico. Highlighted intercepts from this program include 30.2g/t Au over 8.1 m in borehole SST-101; 48.9g/t Au over 3.6 m in borehole SST-118; and 34.4g/t Au over 4.6m in borehole SSUG-059. The deposit remains open in a number of directions. The 57 holes reported represent all Sub-Sill results received up to September 5, 2018.
Torex Gold Resources, Inc. (TORXF), closed Tuesday's trading session at $10.1658, up 1.14%, on 3,831 volume with 15 trades. The average volume for the last 3 months is 11,822 and the stock's 52-week low/high is $5.73/$11.80.
The QualityStocks Company Corner
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF)
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)
- Plus Products Inc. (CSE: PLUS) (OTC: PLSPF)
- The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF)
- Canopy Rivers Inc. (TSX.V: RIV)
- Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
- Earth Science Tech, Inc. (ETST)
- Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF)
- CytoDyn Inc. (CYDY)
- Youngevity International, Inc. (NASDAQ: YGYI)
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
- Cannabis Strategic Ventures, Inc. (NUGS)
- Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8)
- First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF)
- SinglePoint, Inc. (SING)
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF)
Moments prior to signing a historic 2018 Farm Bill and effectively legalizing industrial hemp, President Donald Trump tweeted out a video of his performance at the 2005 Emmy Awards, singing the song “Green Acres.” Having already passed through the House of Representatives and the Senate, the bill was met with much fanfare across nearly the entire cannabis sector, including benefactors such as Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) (GGB Profile).
Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) is a lifestyle-oriented cannabis and cannabidiol (“CBD”) consumer products company with a portfolio of lifestyle brands customized to connect specific, like-minded customers. Each Green Growth Brand provides the best quality products within a retail experience that appeals to users in an environment that is emotionally branded and easy to navigate.
In the next five years, the cannabis industry will generate more than $28 billion of new revenue from an estimated 14 million new customers, according to Ackrell Capital’s 2018 Cannabis Investment Report. Meanwhile, Hemp Business Journal projects that the CBD market will increase 8x to $3 billion by 2021, up from $200 million in 2017. Green Growth Brand intends to dominate in these markets with a lineup up products grown, manufactured and presented with the highest quality standards in mind.
Products under the Green Growth Brand umbrella include:
- CAMP: A kiosk-type store where consumers can experience beautifully crafted lifestyle products that enhance one’s journey to self-discovery.
- Seventh Sense: A CBD-infused body care collection crafted from the finest botanicals and fragrances on earth. Created to maximize the properties and aromatics of each ingredient, Seventh Sense natural products are CBD-infused botanical therapy.
- Meri+Jayne: Fiercely authentic and wholly unapologetic, Meri+Jayne is a youthful, full-on celebration of what makes each person unique. Expect the unexpected when it comes to this mix of amazing products.
- Green Lily: A place for women to explore a new world of wellness. With advice on every product, from efficacy to usage, Green Lily guides guests through beautiful new ways to experience cannabis and CBD.
- The +Source: Located in Las Vegas and Henderson, Nevada, The+Source dispensaries operated by Green Growth Brands serve both medical patients and retail customers. Green Growth Brands also operates a grow and production facility in Post, Nevada, and recently entered into definitive agreements to acquire a Pahrump, Nevada, cultivation facility.
- XanthicBiopharms is the owner of valuable intellectual property that turns THC(Tetrahydrocannabinol) and CBD into a water-soluble substance. As a result of combining Green Growth Brands and Xanthic, this technology is being used to create incredible new products.
Green Growth Brands has identified numeroushitches in the current cannabis retail space. The company intends to counter these challenges and provide a customer experience ripe with a friendly staff, in-stock assortments, efficient operations and more. The company’s retail partners provide distribution opportunities within 4,000 stores, as well as robust and established digital platforms to best reach the modern consumer.
Green Growth Brands brings together a collection of expert retailers, scientists, botanists, developers, artists and business leaders for the benefit of building community. Led by an executive management team steeped in decades of experience with several of America’s most successful brands, including Victoria’s Secret, American Eagle Outfitters, Bath & Body Works, Limited Brands and Designer Shoe Warehouse, Green Growth Brands is uniquely positioned to create memorable brands, retail experiences, and quality products for the emerging cannabis industry.
Chief Executive Officer Peter Horvath heads strategy and execution across all company channels, and previously took shoe retailer DSW public on the NYSE at $1.5 billion. As a dynamic, creative brand leader, team builder, and specialty retail veteran with deep roots in finance, Horvath’s unique ability to understand the big picture while never missing the subtle details is a critical factor in Green Growth Brands’ success and brand popularity among customers.
Chief Marketing Officer Scott Razek is a brand strategist, storyteller and strategic marketer. Razek‘s 25 years of experience in brand building, product development and customer experience focus are a key differentiator for the Green Growth Brands portfolio.
CAO Ed Kistner brings 33 years of multifaceted experience at leading retail businesses, notably in finance, merchandise planning, operations and stores. His well-rounded experiences in fast-changing environments position Kistner to be the architect of the operational execution at Green Growth Brands.
CSO Kellie Wurtzman brings significant retail leadership to Green Growth Brands with a proven track record of leading high-performance stores and teams across multiple retail sectors. Her unmatched experience in identifying and supporting developing business opportunities is ideal for evolving the cannabis industry and will be instrumental in expanding operations at Green Growth Brands.
Headquartered in Columbus, Ohio, Green Growth Brands is traded on the Canadian Securities Exchange and on the OTCQB, providing investors with increased access to data, transparency and liquidity.
Green Growth Brands Inc. (OTCQB: GGBXF), closed the day's trading session at $3.79, up 2.82%, on 140,496 volume with 241 trades. The average volume for the last 3 months is 149,512 and the stock's 52-week low/high is $1.8068/$4.25.
- US President, Producers Envision ‘Green Acres’ with Signing of Historic Hemp-Legalizing Farm Bill
- Xanthic Biopharma Inc. (d.b.a. Green Growth Brands) Announces Name Change to Green Growth Brands Inc.
- Cannabis is Already Disrupting these Top Global Industries
Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE)
Pacific Rim Cobalt Corp. (CSE: BOLT) (FRANKFURT: NXFE) (OTCQB: PCRCF) a Company focused on developing nickel / cobalt opportunities in Indonesia is pleased to provide an update detailing the milestones and growth initiatives accomplished throughout 2018 and strategic goals for 2019.
Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is a Canada-based exploration company focused on the acquisition and development of production-grade cobalt deposits, a key raw material input for the growing lithium-ion battery industry.
Pacific Rim Cobalt and its Cyclops Nickel-Cobalt Project, located in the Depapre District, Jayapura Regency, Papua Province, Republic of Indonesia, is uniquely positioned in a region with potentially the largest source of cobalt outside of Africa. Strategically located near China, the world’s largest cobalt buyer, the Cyclops Project is a laterite (iron-hosted) mineral prospect, rich in cobalt and nickel. Cobalt consumption in China is on-track to use over 8,000 tonnes of cobalt annually by 2021 for electric vehicle production alone and is projected to remain the world’s largest cobalt consumer for many years to come.
Global demand for renewable power is fueling a massive shift from traditional energy supply chain economics to cobalt-reliant lithium-ion batteries, the world’s most widely used power source for portable applications such as electric vehicles and other high-tech applications.
Pacific Rim Cobalt management has concluded that strategic access to major markets offers the most important factor to servicing the rising demand for cobalt. The company’s acquisition of its initial asset in Indonesia offers near surface, strong nickel-cobalt mineralization in an area with excellent infrastructure including a nearby workforce, supplies, sealed roads, ocean access, nearby port facility and gentle topography. The project area, nestled on the north coast of Papua, Indonesia, establishes Pacific Rim Cobalt well within the economically attractive ocean-going transportation range to Asia and its lucrative, growing industrial markets.
Exploration efforts are currently focused on establishing a maiden compliant resource for the Cyclops project, both in historically identified and drill-tested prospects as well as previously unexplored areas of the claims. During the first nine months of 2018, the company focused on assembling the necessary agreements to access northern areas of the project hosting historically identified mineralized zones. Mapping, sampling and a mini-bulk sample within the mineralized zones has been completed, along with a small-scale program in the previously unexplored far southern area of the project. With surface access to priority targets now established, Pacific Rim Cobalt will initiate drilling and extract additional mini-bulk samples for further metallurgical testing.
“We are excited and optimistic about the unique possibility of developing this project into an asset that will add shareholder value and position the company to play a future role in the battery metals supply chain,” Pacific Rim Cobalt CEO Ranjeet Sundher recently stated (http://nnw.fm/u1HNs). “We expect the near-surface nature of cobalt/nickel mineralization at the Cyclops project will lend itself well to low-cost, logistically straightforward drilling. We thus anticipate the opportunity to undertake a resource calculation study, as well as ongoing metallurgy and process option testing, will present itself in the near future. It’s going to be a busy year ahead, and we look forward to getting the drills turning and building value.”
Pacific Rim Cobalt’s world-class management team includes Sundher, who has over 20 years of capital markets experience. Sundher is also president of Canrim Ventures Ltd., a Singaporean advisory firm specializing in early stage project finance and structure. He previously founded Indogold Exploration, a Jakarta-based mining service firm, and has raised over $40 million for companies in which he was a founder/partner.
Chief Financial Officer Steve Vanry has 25 years of professional experience in senior management positions with public and private natural resources companies, providing expertise in capital markets corporate finance, mergers and acquisitions, regulatory compliance, accounting and financial reporting.
Andre Talaska serves as country manager and technical supervisor. He has over 30 years of experience in the mining and exploration industry and has held senior positions with several companies in Australia and southeast Asia. Shakir Juffry, business development/engineering, is a chemical engineer and extractive metallurgist by background training who has over 20 years of experience in the Indonesian mining and minerals exploration field. Toto Suarto Sajali, operation and development manager, is a mining engineer with over 15 years of experience in Indonesian project assessment, development and operations.
Pacific Rim Cobalt Corp. (OTCQB: PCRCF), closed the day's trading session at $3.79, up 2.82%, on 10,000 volume with 3 trades. The average volume for the last 3 months is 14,022 and the stock's 52-week low/high is $0.0701/$1.166.
- Pacific Rim Cobalt Provides Update to Shareholders on 2018 Progress
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) is “One to Watch”
- NetworkNewsBreaks – Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Focusing on Acquisition and Development of Production-grade Cobalt Deposits
Plus Products Inc. (CSE: PLUS) (OTC: PLSPF)
Plus Products Inc. (CSE: PLUS) announced in December 2018 that it had finalized the acquisition of GOOD CO-OP Inc. – a California-based cannabis-infused baked goods brand. This acquisition is expected to enable Plus to solidify its top position in the edibles field (http://nnw.fm/572iG).
Plus Products Inc. (CSE: PLUS) (OTC: PLSPF) is a branded cannabis-infused products manufacturer of edibles created to support a healthy and active lifestyle. Headquartered in San Mateo, California, PLUS™ concentrates on producing edibles using extracts to ensure compliant, dosable and delicious products that provide a consistent cannabis experience.
First introduced to the market in 2015 to rave reviews, PLUS™ is now one of the top best-selling edible brands in California. PLUS™ operates through a wholly owned subsidiary, Carberry, and has four cannabis-infused gummy candy SKUs (in addition to limited edition SKUs), that are currently sold in over 200 licensed dispensaries and delivery services. All products under the PLUS™ brand are produced in the company’s 12,000-square-foot food-safe cannabis manufacturing facility in Adelanto, California.
PLUS Products shares are currently listed on the Canadian Securities Exchange. PLUS™ raised CAD$20 million through the offering, for which the lead underwriters were PI Financial and Canaccord Genuity. The company intends to use a portion of the IPO proceeds to fund rapid product capacity expansion, factory automation, working capital and new product development.
Operating in the largest adult-use recreational market in the U.S., PLUS Products holds a temporary manufacturing license in California and was one of the first brands to bring fully compliant products to the legal market. California legalized adult use recreational sales on Jan. 1, 2018, and industry analysts expect edible sales there will continue to amass enviable revenues. According to BDS Analytics, edibles made up 18 percent of marijuana retail sales in February 2018 across licensed retailers in California, with PLUS™ products ranking in the Top 10 of edible brands by retail dollar sales.
During the first half of 2018, PLUS Products generated US$2.45 million in sales, a marked improvement over 2017’s US$1.07 million in sales. The company’s established cannabis products are not only compliant with state laws, they are proving to be extremely popular with consumers. Among the PLUS™ product brands are:
- Blackberry & Lemon RESTORE, an infusion of carefully dosed cannabis with a 9:1 THC to CBD per gummy.
- Sour Watermelon UPLIFT, a low-calorie gummy crafted from carefully dosed cannabis with an infusion of 5mg THC per gummy.
- Pineapple & Coconut CBD RELIEF, a tropical flavor gummy made from pure cannabis-derived CBD that is low-calorie, gluten-free and made with kosher ingredients.
- Sour Blueberry CREATE, a low-calorie gummy infused with hybrid flower containing 5 mg THC.
- Limited Edition Rose & Vanilla, available at select locations during Winter 2018, these gummies are crafted with 60 mg THC/30 mg CBD per tin.
- Limited Edition RAINBOW SORBET gummies was created to celebrate Pride during Spring 2018 with a portion of each purchase donated to The Trevor Project, a confidential suicide hotline for LGBT youth.
“We are extremely proud of the products PLUS has brought to market,” remarked Jake Heimark, CEO and cofounder in a statement. “We’ve quickly grown into one of the leading edible brands in California. With the proceeds of this round, we will continue to further our mission: to make cannabis safe and approachable for all types of consumers.”
The PLUS™ team believes that everyone deserves access to consistent, dosable and delicious cannabis products and strives to make that happen. Producing the best infused products at scale requires thoughtful collaboration among experts in many fields. At PLUS™, our team is comprised of Chefs, Chemists, Food Manufacturing Experts, Engineers, Machinists, Visionaries, Creatives, Strategists and others.
Plus Products Inc. (PLUS), closed the day's trading session at $4.55, up 4.12%, on 11,600 volume with 16 trades. The average volume for the last 3 months is 109,309 and the stock's 52-week low/high is $2.81/$4.25.
- Plus Products Inc. (CSE: PLUS) Solidifies Leading Edibles Position in California with Acquisition of Cannabis-Infused Baked Goods Manufacturer
- Benzinga Cannabis Capital Conference Will Bring Cannabis Visionaries and Investors Together
- 420 with CNW – Medical Marijuana May Soon Be Allowed in Federally Subsidized Housing
The Flowr Corporation (TSX.V: FLWR)
The Flowr Corporation’s (TSX.V: FLWR) (OTC: FLWPF) acquisition of 19.8 percent of Holigen Limited for a cash payment of C$6 million and the signing of an intellectual property sharing agreement is expected to have far-reaching benefits for the company. Flowr says that it will result in an acceleration of Holigen’s projects, including an outdoor cultivation license on a seven million square foot site in Portugal with the potential to produce 500,000 kg of cannabis products annually (http://nnw.fm/iv7Wk).
The Flowr Corporation (TSX.V: FLWR), a Health Canada Licensed Producer (LP) of cannabis under the Access to Cannabis for Medical Purposes Regulations (ACMPR), is an emerging Canadian cannabis leader founded by Medreleaf co-founder Tom Flow and a team of industry pioneers, successful start-up executives and top industry scientists. Flowr’s purpose-built cultivation facilities may be the most advanced in the industry, consistently generating high crop yields, delivering premium and ultra-premium cannabis products, and maximizing return on investment. The company also may be an R&D leader as it was selected by the Hawthorne Gardening Division of The Scotts Miracle-Gro Company as its exclusive Canadian cannabis R&D partner.
Flowr’s flagship facility, an 84,000-square-foot campus on seven acres in Kelowna, British Columbia, is engineered to grow premium cannabis in rooms that meet pharmaceutical industry production standards for cleanliness. This, along with exacting protocols designed by the Flowr team, enables Flowr to grow cannabis that meets Health Canada’s stringent standards without treating it with the taste- and smell-killing gamma irradiation that most other producers have to use to clean their product. Irradiating the plant – a process similar to pasteurizing food – impairs many of the important terpenes that provide the positive effects, flavors and scents of cannabis while strengthening unpleasant terpenes. Flowr’s products may deliver a better user experience, thus commanding premium prices.
Flowr’s cultivation facilities, built with proprietary, patent-pending systems, are designed to deliver yields targeted at 450 grams per square foot by the end of 2022, which is three times more efficient than the industry average of approximately 150 grams per square foot. By optimizing yield, the Company may produce significantly more cannabis flower on a smaller footprint than other producers, thus generating far high revenue per square foot and keeping costs much lower, leading to higher margins. The Kelowna facility is presently 20 percent operational with the remaining 80 percent slated to come online by early 2019. It is expected to produce up to 14,000 kg of premium, non-irradiated cannabis flower in 2019. With further enhanced yields and planned expansion of production facilities on the campus, Flowr will reach a total capacity of 60,000 kg annually in 2022.
Leading Flowr’s cultivation program is industry pioneer, company co-founder and Flowr president Tom Flow. Flow is widely recognized for his cannabis thought leadership and expertise building and operating cannabis cultivation facilities. Flow also co-founded MedReleaf and designed, built and set up SOPs for their flagship Marcum cultivation facility. Marcum has continued to be perhaps the most productive facility in the country prior to the Flowr flagship facility. Long one of Canada’s most efficient and profitable LPs, MedReleaf was acquired by Aurora for approximately C$3 billion. Flow and his team have designed and built a total of 17 cultivation facilities and secured three producer’s licenses under various Canadian regulatory regimes.
In March 2018, Flowr and the Hawthorne Gardening Division of The Scotts Miracle-Gro Company – a world leader in lawn and garden products – announced an exclusive strategic R&D alliance. After evaluating numerous Canadian LPs, Hawthorne chose to partner with Flowr based on the experience and expertise of the company’s cultivation and R&D teams and the company’s advanced growing capabilities.
Hawthorne will fund the construction of a 50,000-square-foot R&D facility that is integrated into Flowr’s Kelowna campus. This facility is North America’s first dedicated cannabis R&D facility focused on advancing cultivation techniques and systems. The facility will support researchers from both organizations and combine laboratories, indoor and greenhouse grow suites, training areas and genetics breeding areas in a single building. It is expected to open in early 2019. In addition to helping Flowr maintain its competitive advantage in cultivation, the company’s R&D program will keep it on the cutting edge of cannabis innovation.
Flowr is entering the market with three different brands to meet the growing demand for premium, non-irradiated cannabis in the medicinal and adult use markets:
- FlowrRx, featuring premium quality medicinal cannabis that enables patients to live better, fuller lives. A dedicated Client Services team will provide patients with personalized support while an R&D team develops innovative flower strains and premium products targeted to specific conditions. Patient well-being is considered at every stage of the process – from genetic selection to harvest, trimming and curing techniques. FlowrRx and its team of passionate scientists and leading cultivation specialists are dedicated to advancing the scientific understanding of cannabis.
- Flowr is the company’s premium recreational adult-use brand featuring an active, West Coast-inspired lifestyle for the cannabis connoisseur and enthusiast market. Through the continuous innovation of procedures and practices, Flowr’s talented team of experts is crafting premium products that deliver unparalleled experiences.
- Ace Valley, an exclusive partnership with top-selling Ontario craft beer company Ace Hill, will bring Flowr’s premium product to the millennial and casual adult-use markets under the Ace Valley brand.
Flowr recently signed a Memorandum of Understanding with the British Columbia Liquor Distribution Branch, the province’s sole legal wholesaler of non-medical cannabis, to supply premium and ultra-premium flower to the province’s retail outlets. The company has agreements with several major medical distributors and is in discussions about retail distribution with additional provinces where it believes it can obtain prices commensurate with the quality of the Flowr products. The company is also evaluating other market opportunities including export.
Flowr is poised to become the pre-eminent indoor premium cannabis grower in Canada and one of the country’s top five LPs. The company’s focus on yield, quality and price point and its team’s ability to grow at scale should drive high margins, significant growth and strong return on investment.
The Flowr Corporation (TSX.V: FLWR), closed the day's trading session at $4.35, up 0.69%, on 109,558 volume with 146 trades. The average volume for the last 3 months is 89,848 and the stock's 52-week low/high is $2.74/$8.00.
- The Flowr Corporation (TSX.V: FLWR) (OTC: FLWPF) Identifies Acquisition of Stake in Holigen as ‘Transformative Transaction’
- NetworkNewsBreaks – The Flowr Corporation’s (TSX.V: FLWR) High Production Standards Result in Premium Quality Products
- The Motley Fool Touts The Flowr Corporation (TSX.V: FLWR) as ‘One to Watch’ with Supply Glut Looming over Marijuana Industry Horizon
Canopy Rivers Inc. (TSX.V: RIV)
Canopy Rivers Inc. (TSXV:RIV) is pleased to announce it has completed an equity investment in Headset, Inc. (“Headset”), a data and analytics service provider for the cannabis industry. Canopy Rivers subscribed for C$4,084,500 of Series A Preferred Shares in Headset, representing the Company’s first entry into a technology-focused cannabis vertical.
Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers collaborates with Canopy Growth to identify strategic counterparties seeking financial and/or operating support. Headquartered in Toronto, Canada, Canopy Rivers has developed an ecosystem of complementary cannabis operating companies operating throughout the cannabis value chain.
Canopy Rivers, in collaboration with Canopy Growth, has established a diverse portfolio of cannabis industry investments that includes domestic and international companies, licensed producers, late-stage licensed producer applicants, pharmaceutical formulators, brand developers and distributors, retail networks, and technology and media platforms. Investments are customized for each counterparty and include a balanced mix of equity, debt, royalty and profit-sharing agreements.
Canopy Rivers’ expanding portfolio includes:
- Agripharm Corp. (private) is an ACMPR licensed producer, acquired by Canopy Growth in January 2017. In November 2017 Agripharm completed a joint venture with globally recognized partners Green House Seeds and Organa Brands. Canopy Growth has sublicensed proprietary technology, trademarks, genetics, know-how and other intellectual property from Agripharm to distribute the suite of Green House and Organa Brands products across the country, when permissible.
- CanapaR Corp. (private) owns 80% of CanapaR Italy, a Sicily-based company focused on developing and commercializing Italy’s local hemp cultivation industry through its partnership with the renowned Department of Agriculture at the University of Catania and its rapidly building extraction capabilities for the production of organic CBD oil. CanapaR Italy’s outsource farming model with local Sicilian farmers and its university partnership will provide it with a low-cost source of organic CBD oil, which is increasingly used as an input into new commercial products in the growing health and wellness industries.
- Civilized Worldwide Inc. (private), is a media and lifestyle brand with offices in New Brunswick and California that embraces and highlights modern cannabis culture. Civilized aims to engage the millions of productive, motivated people who choose to enjoy cannabis responsibly as part of their lifestyle. Reaching 2+ million unique visitors per month, North America-wide, Civilized produces engaging content for and about people who enjoy cannabis responsibly.
- James E. Wagner Cultivation Ltd. (TSXV:JWCA) was founded in 2007 by third generation agricultural and cannabis cultivators. JWC is the first entirely aeroponic producer of cannabis in Canada, and its patent-pending aeroponic production technology, called GrowthStormTM, allows for perpetual harvesting and improved yields. The company was issued a license to cultivate from Health Canada in January 2017 and a subsequent sales license in March 2018.
- LiveWell Foods Canada Inc. (TSXV:LVWL) was established in 1993 as a nutritional lifestyle company, and operates in the production of fresh produce and food technology. The company’s O-Hemp division distributes bulk and retail hemp products through its existing channel partners. LiveWell entered into a strategic agreement with Canopy Rivers and Canopy Growth in April 2018.
- PharmHouse (private) is a joint venture between Canopy Rivers and the principals and operators of leading North American greenhouse produce companies. PharmHouse has arranged to acquire a newly built 1.3-million-square-foot greenhouse located in Leamington, Ontario.
- Radicle Cannabis Inc. (private) is an ACMPR-licensed cannabis company based in Hamilton, Ontario backed by a management team that brings extensive experience in regulated industries, retail distribution, tobacco and pharmaceutical development, as well as Award-winning cannabis horticulturist breeders and medical professionals.
- Solo Growth (TSXV:ALZ) is a premiere retail cannabis distributor that will operate locations under the name “YSS by Solo,” relying on the expertise of a management team comprised of founding shareholders, senior officers and board members of Canada’s largest private liquor retailer, Solo Liquor, who collectively have more than 50 years of regulated substance retail experience. Solo Growth was established through a recapitalization of Aldershot Resources Ltd.’s corporate structure that will allow the company to execute a new retail-focused cannabis business strategy as “Solo Growth Corp.”
- Spot Therapeutics Inc. (private) is an applicant that was acquired by Canopy Growth in August 2017 to solidify its Maritimes expansion strategy and less than four weeks later Canopy Growth signed a supply MOU with the New Brunswick government. Canopy Rivers purchased the property and entered into a long-term lease and committed funding agreement with Canopy Growth.
- TerrAscend Corp. (CSE:TER) cultivates high-quality cannabis in an indoor hydroponic facility, backed by a strategic investor boasting a strong background in the pharmaceutical space and an extensive portfolio of specialty pharma assets.
- Vert Mirabel (private) is a joint venture that was established in December 2017 between Canopy Rivers, Canopy Growth, and Les Serres Stephane Bertrand. Bertrand is a large-scale greenhouse operator located in Mirabel, Quebec, and the largest grower of pink tomatoes in the country. With guidance and assistance from Canopy Growth, the greenhouse has been upgraded and retrofitted for cannabis production and was licensed by Health Canada in May 2018.
As the company’s portfolio continues to develop, each constituent benefits from opportunities to collaborate with Canopy Growth and among themselves. Canopy Rivers believes this formula results in an ideal environment for innovation, synergy and value creation for Canopy Rivers, Canopy Growth and across the entire Rivers ecosystem.
Canopy Rivers is led by an experienced team of qualified financial and technical professionals with deep industry experience and relationship networks. The company’s acting CEO and chairman is Bruce Linton, CEO of Canopy Growth and founder of Tweed Marijuana.
Canopy Rivers Inc. (TSX.V: RIV), closed the day's trading session at $3.60, up 1.41%, on 395,642 volume with 704 trades. The average volume for the last 3 months is 453,283 and the stock's 52-week low/high is $2.40/$11.82.
- Canopy Rivers Announces Investment in Technology Driven Data Company Headset
- 420 with CNW – Marijuana Law Changes in Mexico and Canada May Finally Change Texas Attitudes
- Canopy Rivers Engages Hybrid Financial for Investor Relations Services
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)
Biotechnology company Lexaria Bioscience’s (CSE: LXX) (OTCQX: LXRP) revolutionary technology, DehydraTECH, alters the way that fat soluble, plant-derived molecules are absorbed into the body. To view the full article, visit: http://nnw.fm/JH6p0.
Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. Though boasting a wide range of health benefits, cannabinoids are traditionally poorly absorbed by the body’s gastrointestinal tract. To achieve higher effectiveness, consumers usually default to smoking. Lexaria provides a superior administration method by delivering hemp oil ingredients – or through locally licensed partners, cannabis oil ingredients – through a patented process within food products.
The key differentiator between Lexaria’s products and others on the market is the company’s disruptive technology proven to enhance the absorption of orally ingested cannabinoids while improving the “unusual” taste of cannabinoids and allowing for lower overall dosing with higher efficacy. Lexaria is primarily a B2B enterprise, and is in licensing discussions or has existing agreements with companies in Canada, the largest-market states in the USA, and internationally. Lexaria has also developed its own brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within lipids in popular foods. These brands include ViPova™, Lexaria Energy Foods, and TurboCBD™.
In 2015, Lexaria commissioned an independent, third-party lab to test its technology under carefully monitored in vitro conditions. Results showed that the company’s technological process and lipid formulation both improve intestinal absorption as much as 500%. Additional follow-up studies in human volunteers suggested that Lexaria’s processed, lipid-infused tea may be more effective in an actual gastrointestinal system than in an in vitro simulation with results indicating as much as a 1,000% increase in overall absorption.
Lexaria also has an R&D partnership with the Canadian government’s National Research Council. That R&D is expected to characterize molecular bond formation theorized to occur with Lexaria’s unique technology between the lipid delivery agents and the bioactive substances it processes and combines. Results from this R&D are expected to support accelerating B2B relationships – not just in the cannabis industry, but also to support new B2B business relationships in the fields of vitamins, NSAIDs, and nicotine delivery. All of these sectors expected to offer additional future growth potential.
Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong intellectual property portfolio that utilizes the most commonly used food processing techniques. As of 2017, the company’s patent portfolio includes 19 patent applications filed and pending in more than 40 countries around the world. The most recent patent applications expand Lexaria’s lipophilic food and beverage composition claims to include the processing of cannabinoids, vitamins, NSAIDs and nicotine in many of the world’s most commonly used food processing ingredients. Lexaria is expecting additional new patent awards both in the USA and internationally in 2017 and 2018.
Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology (royalty) to third party partners, and has several deals signed and/or pending. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has raised more than $50 million in working capital for the companies he has led over the course of his career. He is supported by a team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods, and other relevant skillsets.
Lexaria Bioscience Corp. (LXRP), closed the day's trading session at $1.01, up 4.12%, on 102,200 volume with 67 trades. The average volume for the last 3 months is 177,888 and the stock's 52-week low/high is $0.75/$2.43.
- NetworkNewsBreaks – Lexaria Bioscience Corp.’s (CSE: LXX) (OTCQX: LXRP) Proprietary Technology Transforms the Way Molecules Enter the Body
- NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Brings Aggressive Growth Plan to Action
- Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Attend Cantech Investment Conference 2019, January 29-30 in Toronto
Earth Science Tech, Inc. (ETST)
Earth Science Tech, Inc. (OTCQB: ETST) (“ETST" or the “Company"), an innovative biotech company focused on the cannabidiol (CBD), nutraceutical and pharmaceutical fields, medical devices, and research and development, today announces its partnerships with communication agencies Les Fous de la Com and Priori System to promote the Hygee™ medical device for the self-screening of Chlamydia.
Earth Science Tech, Inc. (ETST) is an innovative biotechnology company operating in the fields of hemp cannabinoid (CBD), nutraceutical, pharmaceutical and medical device research and development. Earth Science Tech offers the highest purity and quality, full-spectrum, high-grade hemp CBD (cannabidiol) oil on the market. Made using the supercritical CO2 liquid extraction process, the company’s CBD oil is 100 percent natural and organic. Earth Science Tech has partnered with the University of Central Oklahoma and DV Biologics Laboratory to conduct research and development projects that scientifically support and advance the healthcare benefits of its high-grade hemp CBD oil.
Earth Science Tech Inc. currently has three wholly owned subsidiaries focused on developing its role as a world leader in the CBD space and expanding its work in the pharmaceutical and medical device sectors. These subsidiaries include:
- Earth Science Pharma, Inc., which is committed to development of low cost, noninvasive diagnostic tools, medical devices, testing processes and vaccines for sexually transmitted infections and/or diseases. Earth Science Pharmaceutical CEO and chief science officer Michel Aubé is leading the company’s research and development efforts. The company’s first medical device, MSN-2, is a home kit designed for the detection of STIs, such as chlamydia, from a self-obtained gynecological specimen. Earth Science Pharma is working to develop and bring to market medical devices and vaccines that meet the specific needs of women.
- Cannabis Therapeutics, Inc. (“CTI”), which is poised to take a leadership role in the development of new, leading-edge, cannabinoid-based pharmaceutical and nutraceutical products. CTI is invested in research and development to explore and harness the medicinal power of cannabidiol. The company holds a provisional application patent for a CBD product that is focused on developing treatments for breast and ovarian cancers.
- KannaBidioiD (“KBD”) provides a wide variety of products geared toward the recreational space of cannabis. KBD’s unique Kanna and CBD formulation is sold and distributed in CBD-infused edibles and vapes/e-liquids products. Kanna and CBD synergistically enhance one another, providing optimal relaxation, an uplifting sensation, enhanced focus and the added benefit of assisting with nicotine reduction therapy.
Earth Science Tech celebrated a significant, developmental year during 2017 by sharing its achievements in a condensed end-of-year report. Among the report’s highlights are the implementation of a development plan for the coming three years, which includes expanding into Canada and opening new manufacturing and shipping facilities. Of particular interest is the acquisition of Canna Inno Laboratories Inc., a company headquartered in Montreal, Quebec, Canada, which gives Earth Science Tech access to Canadian government grants offered to innovators in the pharmaceutical industry. ETST has also launched development of proprietary prophylactic therapies utilizing cannabidiol (CBD) to treat various forms of breast cancer.
In October 2017, ETST announced it is cooperating with the Clinique SIDA Amité (AIDS Friendship Clinic) for a mini-clinical trial, the last trial needed before the MSN-2 device, designed for the detection of STIs, enters molecular diagnostic trials. And in November 2017, the company began pre-launch human trials on a new CBD formula to fight against the U.S. opioid epidemic. The new formula, expected to decrease cravings and the negative effects of withdrawal in addicts, is based on industrial hemp CBD mixed with a known natural ingredient proven to help increase dopamine levels. ETST’s medical devices will first be launched in Vietnam, Djibouti and Morocco while the company awaits regulatory permission to enter the North American market.
The company expects to up-list to the OTCQB in early 2018, which management believes will attract well-funded institutional investors and pave the way to becoming the next billion-dollar-in-capitalization company on the OTC markets. Other highlights include completion of the company’s Scientific Advisory Council with a team of recognized scientists, the launching of several CBD-infused edible products and entry into the medical devices market through collaborative partnerships.
Earth Science Tech has signed a collaborate agreement with Laboratories BNK Canada, a private laboratory that will conduct the clinical studies necessary for MSN-2 medical device-related services to meet regulatory requirements. ETST has confirmed the MSN-2 device’s ability to detect chlamydia, and is working to validate similar results for gonorrhea, both highly infectious diseases that often have permanent consequences for patients. ETST will also add testing for trichomoniasis and a complete body fluid panel to detect the different serotypes of the human papillomavirus (HPV) that causes cervical cancer. These additions will help the company create sales opportunities in the global market for diagnostic testing of STDs that Transparency Market Research has indicated will grow to $108 billion by 2019.
Cannabis Therapeutics is in the development stage of two cannabinoid-based pharmaceutical drugs and three cannabinoid-based nutraceutical products targeting a variety of ailments such as anxiety, depression, triple negative breast cancer, and fatty liver disease, among others. Research into the benefits of the non-psychoactive cannabinoid molecules found in the cannabis plant is supported by ETST’s International Application for Provisional Patent titled “Cannabidiol Compositions Including Mixtures and Uses Thereof,” which was filed on October 8, 2015. Cannabis Thera’s R&D efforts are concentrated on developing CBD-based drugs and nutraceutical products and in working to integrate the CBD molecule with existing generic drug molecules to create more efficient medications with fewer and less severe side effects. A report in Hemp Business Journal predicts the CBD consumer market will grow to $2.1 billion by 2020, while other industry experts expect an increase to almost $3 billion by 2021. A recent report by Statista projects the U.S. consumer market for cannabinoid-based pharmaceuticals could reach $50 billion by the year 2029.
The management team at Earth Science Tech brings decades of invaluable experience to the nutraceutical, dietary supplement field as well as the life sciences sectors. Nickolas S. Tabraue, who serves as the president, director and chief operating officer, is an industry veteran with extensive knowledge of supplements, retail management, customer service and sales expertise. He is joined by CEO and CSO Dr. Michel Aubé, a microbiologist whose scientific research in sexually transmitted infections, cancer and stem cell biology has been widely published in several prestigious medical journals. Sergio Castillo, chief marketing officer, and Gabriel Aviles, chief sales officer, bring a wealth of marketing and sales experience to Earth Science Tech, which is complemented by Issa El-Cheikh, Ph.D., and his 25 years in the international finance, accounting, planning and execution of large scale transactions in the public and private sectors.
Earth Science Tech’s products include CBD, a natural constituent of hemp oil derived from hemp stalk and seed. EST offers CBD in the form of vitamins, minerals, herbs, botanicals, personal care products, homeopathies, functional foods and other products delivered in such forms as capsules, tablets, soft gels, chewables, liquids, creams, sprays, powders and whole herbs. Earth Science products can be found at retail stores throughout the United States and are available for purchase through the internet.
Earth Science Tech, Inc. (ETST), closed the day's trading session at $0.7699, up 3.97%, on 21,683 volume with 20 trades. The average volume for the last 3 months is 57,591 and the stock's 52-week low/high is $0.421/$2.45.
- Earth Science Tech, Inc. (ETST) Announces Strategic Partnerships to Market Hygee™ and Address Global Epidemic
- Earth Science Tech, Inc. (ETST) Pushes toward Opportunity with Passing of New Farm Bill and Launch of Hygee Kits
- NetworkNewsBreaks – Earth Science Tech, Inc. (ETST) Reviews Numerous Major Achievements and Positioning for Pivotal 2019
Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF)
Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF) is pleased to announce that it has appointed South American lithium expert, Jose de Castro Alem, to the Board of Directors and as Manager of Lithium Operations. Mr. de Castro is a recognized pioneer in lithium brine exploration, development and production in South America. He brings over 20 years of lithium brine experience, as well as a significant track record in the lithium triangle, to the Company's management team. Jose de Castro Alem's appointment is subject to regulatory approval.
Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF), headquartered in Canada, is advancing one of the largest lithium-rich exploration portfolios in Chile consisting of more than 148,000 hectares covering sections of 13 salars or mineral salt flats and one laguna complex. The company’s wholly owned premier properties include 66 square kilometers on the Salar de Atacama, Chile’s largest mineral salt flat which hosts the world’s highest concentration of lithium brine production and is currently the source of about 35 percent of the world’s lithium production. Lithium Chile also owns a significant copper/gold/silver property portfolio consisting of 28,184 hectares over six different properties.
Lithium Chile’s portfolio in the heart of Chile’s lithium-rich salars includes Salar de Coipasa, Salar de Helados, Salar de Atacama, Salar de Turi Salar de Ollague and Salar de Talar. Surface and near surface salt and brine sampling programs on all properties has been completed. To date, samples of high-grade, near-surface lithium brines at each of these projects are showing excellent chemistry of lithium to potassium and lithium to magnesium ratios. Good chemistry is important as it reduces your overall cost of production. Recent geophysical surveys including T.E.M have been completed on 5 of 6 priority targets and data collected to date has been extremely encouraging.
Lithium Chile has identified multiple high-priority brine target areas at its Atacama and Ollague lithium project areas. These areas display the same geophysical characteristics as the lithium-rich aquifers at Salar de Atacama, home to the world’s largest and highest-grade lithium brine producers. Spanning an area of 1,200 square miles, Salar de Atacama is the world’s third largest salt flat behind Salinas Grandes in Argentina and El Salar de Uyuni in neighboring Bolivia. Exploration drilling and resource definition drilling for these target areas are planned for 2018.
“We are delighted with the discovery of such impressive drill target areas at Atacama and Ollague. The results also follow the recent discovery of a 60km2 target area at another of our top Chilean projects – Helados – where we hope to drill in the second quarter of 2018,” stated President and CEO Steve Cochrane. “We have an aggressive multi-project drill program planned for this year, which includes all three of these exciting projects and we look forward to sharing drill results as they come through.”
Global demand for lithium-ion batteries is expected to surpass US$53 billion by 2024 as governments around the world aggressively seek to ban gas-powered vehicles and major automakers invest billions in new technology and electric vehicles powered by lithium-ion batteries. Chile’s mining-friendly jurisdiction offers Lithium Chile a clear, streamlined permitting process that significantly lowers the cost of lithium production to around $1,800/ton as compared to Australia’s $5,000/ton.
Lithium Chile is led by an experienced team with strong Chilean connections. Cochrane’s 36 years of investment industry experience have primarily been focused on the mining sector. During this time, he raised more than US$500 million for a variety of small cap public companies in various businesses and industry sectors including mining.
Terry Walker, P.Geol., vice president of exploration and chief geologist, is a highly experienced geologist. He has spent over 25 years in Chile’s mining industry and is well connected throughout the sector. Walker is co-founder of GeoServicios Piedra Dorada, an exploration and development services company focused on Latin America. He is a Qualified Person for the North American and Australian stock exchanges.
Lithium Chile is well funded and driven by a top-tier team with more than 100 years of combined experience in financing, mining exploration and development in the natural resources sector.
Lithium Chile Inc. (LTMCF), closed the day's trading session at $0.4212, up 7.20%, 4,280 volume with 6 trades. The average volume for the last 3 months is 28,562 and the stock's 52-week low/high is $0.344/$0.97.
- Lithium Chile Enhances Technical Team and Board of Directors; Appoints Leading Lithium Expert, and Grants Stock Options
- Lithium Chile Provides Corporate Update and Announces Expansion to its Helados Prospect
- NetworkNewsBreaks – Lithium Chile Inc. (TSX.V: LITH) (OTCQB: LTMCF) Gears Up for Expected Lithium Shortage
CytoDyn Inc. (CYDY)
CytoDyn Inc. (OTC.QB: CYDY), a biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, today announced that it will be presenting an update on the company’s clinical development programs and objectives for leronlimab (PRO 140) during the Biotech Showcase on January 9, 2019 at 10:30 a.m. PT. More information regarding the conference can be found at https://ebdgroup.knect365.com/biotech-showcase/
CytoDyn Inc. (CYDY) is a biotechnology company focused on the clinical development and potential commercialization of a new class of HIV/AIDS therapeutics or viral-entry inhibitors intended to protect healthy cells from viral infection. The company’s pipeline includes its lead product, PRO 140 for multiple indications among which are human immunodeficiency virus (HIV), graft-versus-host disease (GvHD), colon cancer, and multiple sclerosis (MS), each in various stages of development. CytoDyn first approval is focused on HIV indications for two different HIV populations.
PRO 140 is a humanized monoclonal antibody directed at CCR5, a molecular portal that HIV uses to enter T-cells. PRO 140 works by blocking the predominant HIV (R5) subtype entry into T-cells by masking this required co-receptor, CCR5.
CytoDyn has completed one pivotal phase 3 clinical trials of PRO 140 use in combination with current drugs for population that has limited treatment options. PRO 140 is also currently in another phase 3 (investigative trial) for a second approval for another HIV population. HIV continues to be a major global public health issue. There is no cure for the disease that has claimed more than 35 million lives to date, according to the World Health Organization (“WHO”). In 2017, 940,000 people around the world died from HIV-related causes. There were approximately 36.9 million people living with HIV at the end of 2017 with 1.8 million people becoming newly infected during that same year. The WHO estimates there were 21.7 million people globally receiving antiretroviral therapy (“ART”) in 2017.
HIV targets the immune system and weakens the body’s defense systems against infections and some types of cancer. As the virus destroys and impairs the function of immune cells, infected individuals gradually become immunodeficient which results in increased susceptibility to a wide range of infections, cancers and other diseases that people with healthy immune systems can fight off. The most advanced stage of HIV infection is Acquired Immunodeficiency Syndrome (AIDS), which can take from 2 to 15 years to develop depending on the individual.
PRO 140 functions by blocking the HIV co-receptor CCR5, a molecular portal HIV uses to enter T-cells, thus preventing the HIV virus from entering the cell. CCR5 is a protein located on the surface of white blood cells that normally serves as a receptor for chemicals that attract immune cells to the site of inflammation. Clinical trials to date indicate PRO 140 does not interfere with these normal CCR5 functions. Results from phase 1 and phase 2 human clinical trials have shown PRO 140 significantly reduces viral burden in people infected with HIV. Importantly, in a recent phase 2b clinical trial, PRO 140 demonstrated it can allow a subset of R5 strain of HIV population to replace their current HIV regimen (Highly Active Antiretroviral Therapy or “HAART.”) by a simple sub-cutaneous self-injectable dose of PRO 140 which is administered once a week. Some of those patients have received PRO 140 as their only therapy for almost four years.
The PRO 140 antibody appears to be a powerful antiviral agent with hardly any side effects, toxicity. More than 500 patients have used PRO 140 in clinical trial and no resistance has ever been developed in any patients including patients in monotherapy of PRO 140 for almost four years.
PRO 140, which is taken as an easy-to-use, weekly, subcutaneous self-administered dose, has almost no side effects or toxicity with no report of any serious adverse event related to PRO 140 in more than 500 patients in eight different clinical trial.
As we indicated earlier patients given PRO 140 showed no drug resistance on monotherapy for some almost four years while 76% of HAART patients developed a resistance to some portion of the lifetime drug regimen. Patient compliance with HAART is also the main reason why only 35% of HIV patients in US reporting complete viral load (VL) suppression which is VL<50 cp/mL.
In addition to its research into the powerful potential of PRO 140 for use in HIV patients, CytoDyn is pursuing PRO 140 as a therapeutic anti-viral agent in other non-HIV indications that could benefit from PRO 140’s ability to block CCR5. These immunologic indications include new reactions to cancer, transplantation rejection, autoimmune diseases and chronic inflammation such as Multiple Sclerosis. The company sees the significant potential for multiple pipeline opportunities for PRO 140.
The U.S. Food and Drug Administration has designated PRO 140 as a “fast track” product for HIV and granted Orphan Drug Designation to it for the prevention of GvHD in transplant patients. CytoDyn has initiated its first clinical trial with PRO 140 in an immunological indication for GvHD in patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) who are undergoing bone marrow stem cell transplantation. The company is also investigating PRO 140 in animal models of cancer progression and autoimmunity with positive results and has published its animal study results in GvHD in peer-reviewed journal.
CytoDyn president and CEO Nader Z. Pourhassan, Ph.D. joined the company in 2008 and is credited for purchasing PRO 140 from Progenics in 2012 and has taken a new path to approval for the product. He is the co-inventor of monotherapy path for PRO 140. He has taken PRO 140 development from phase 2 to Completed successful phase 3 in about four years. He now has more than 10 years of drug development experience and has overseen the rapid clinical development of PRO 140 as a therapy for HIV into two phase 3 for two different indications. He also initiated PRO 140 first immunological indication in GvHD (currently in phase 2). He is also involved in preclinical and clinical development of PRO 140 in additional immunological indications.?Dr. Pourhassan, who has more than 20 years of business development experience, has led CytoDyn’s capital market activities since joining the company in 2008. He received his Bachelor of Science from Utah State University, Master of Science from Brigham Young University, and his Ph.D. in Mechanical Engineering from the University of Utah and is the author of three books.
CytoDyn Inc. (CYDY), closed the day's trading session at $0.570305, up 0.05%, on 332,840 volume with 70 trades. The average volume for the last 3 months is 189,658 and the stock's 52-week low/high is $0.40/$0.836.
- CytoDyn to Deliver Presentation at Biotech Showcase Conference
- CytoDyn Names Richard G. Pestell, M.D., Ph.D. as Vice Chairman of its Board of Directors
- NetworkNewsBreaks – CytoDyn Inc. (CYDY) Foresees Market Availability of PRO 140 by 2020
Youngevity International, Inc. (NASDAQ: YGYI)
Youngevity International, Inc. (YGYI), a leading omni-direct lifestyle company, announced today that its wholly-owned subsidiary, CLR Roasters, has begun processing and shipping its first containers of green coffee under its recently entered 5-year green coffee contract. The company already has orders against the contract for 230 containers scheduled to ship in the first quarter of this year. The initial coffee shipments are for predominantly Strictly High Grown washed Nicaraguan conventional coffees, although 15 containers of naturals were part of the initial shipments.
Youngevity International, Inc. (NASDAQ: YGYI) is a leading omni-direct lifestyle company offering a hybrid of the direct selling business model that includes e-commerce and the power of social selling. Among the Top 100 Global Direct Selling Companies, Youngevity offers products from the six top selling retail categories: health/nutrition, home/family, food/beverage (including coffee), spa/beauty, apparel/jewelry, and a range of innovative services. Created through the 2011 merger of Youngevity Essential Life Sciences with Javalution® Coffee Company, today’s Youngevity International Inc. is a virtual worldwide Main Street of products and services under one corporate entity that supports a healthy and empowered lifestyle.
Youngevity International is dedicated to improving lifestyles through the universal desires of vibrant health and flourishing economics. Catering to health-conscious consumers, Youngevity believes that combining the best of the direct selling industry with the fundamentals and capabilities of a traditional business model will maximize shareholder value. The company’s Nutritional, Lifestyle and Telecommunications products and services are distributed through a global network of Preferred Customers and Distributors.
Youngevity’s wholly owned CLR Roasters LLC business line offers quality branded and private label coffee to retail stores, office coffee services, hospitality, food services, distributors, convenience, petrol stores and vending businesses. Today, CLR Roasters is the largest coffee provider for cruise lines in North America and the second largest roaster in the state of Florida. Producing a consistent premium product with superior taste, CLR Roasters has earned numerous certifications that demonstrate the company’s commitment to the craft of providing the highest quality coffee products using the best practice standards available.
Youngevity, operating in the direct-selling channel, is rapidly expanding its product and distributor base through acquisitions and mergers under an innovative concept called “the Network Cloud” that provides other direct selling companies with a home base. The company’s YoungevityGO2 mobile distributor app, a new technology-driven web platform supporting expansion of global e-commerce and social selling platforms, is available on Google Play and the App Store. In addition to the Network Cloud concept, Youngevity International owns CLR Coffee Roasters which operates a traditional coffee roasting business offering a JavaFit® gourmet product line that vertically integrates with Youngevity and its growing network of direct marketers.
Youngevity International offers more than 1,000 high quality, technologically advanced products under the following categories:
- Health and Nutrition
- Home and Family
- Food and Beverage
- Spa and Beauty
- Essential Oils
- Photo and scrapbooking
- Services for Home and Business
Youngevity International Inc. has compiled a best-in-class management team with a strong track record of success in private and public companies. Steve Wallach, CEO, has nearly two decades of sales and network marketing experience and has successfully guided Youngevity International Inc. to become an international, publicly-traded direct marketing company positioned for worldwide growth. Dave Briskie, president and CFO, has shepherded the company’s development into a fully vertical coffee roasting and distribution company that owns the direct marketing brand JavaFit® and the retail brand, Café La Rica.
Youngevity has also attracted a stunning group of Brand Evangelists who endorse its products. Among these are actress, author and well-known health and wellness activist Marilu Henner; former NBA basket player, Mike “Stinger” Glenn; former NFL wide receiver Drew Pearson; “Greatest Natural Bodybuilder in the World” Gene Nelson; and WNBA champion, Olympic gold medalist Delisha Jones.
Youngevity International, Inc. (NASDAQ: YGYI), closed the day's trading session at $5.15, off by 0.39%, on 107,355 volume with 459 trades. The average volume for the last 3 months is 540,553 and the stock's 52-week low/high is $3.167/$16.25.
- YGYI's CLR Roasters Ships First 3.8 Million Pounds of Green Coffee Under its 5-Year Estimated $250 Million Green Coffee Contract
- NetworkNewsBreaks – Youngevity International, Inc. (NASDAQ: YGYI) Leverages Strengths of Social Selling in its Unique Direct Selling Business Model
- 420 with CNW – Cannabis Drinks Likely to Be a Big Hit in 2019
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF)
The Green Organic Dutchman Holdings Ltd. (TSX:TGOD) (US:TGODF) is pleased to announce it has appointed Dr. Caroline MacCallum and Jacques Dessureault to its Board of Directors. Dr. Caroline MacCallum is one of the world's most prominent experts in cannabinoid-based medicine.
The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF), whose principal location is in Hamilton, Ontario, produces farm grown, organic, pesticide-free medical cannabis in small batches using all natural, organic craft growing principles. TGOD is licensed under the Access to Cannabis for Medical Purposes Regulations (ACMPR) to cultivate medical cannabis. The company carries out its principal activities producing cannabis pursuant to the provisions of the ACMPR and the Controlled Drugs and Substances Act (Canada).
Committed to becoming the global leader in delivering organic cannabis solutions that enhance people’s lives, TGOD consistently adheres to the highest levels of excellence. Its world-class management team includes a proven group of leaders with outstanding executive and operational experience specific to consumer packaged goods, consumer products, cannabis and finance industries.
TGOD is positioned as one of the highest quality and most cost efficient cannabis producers in Canada by leveraging innovative technology and low-cost power solutions. It holds one of the largest land packages under a single ACMPR license in Canada, providing future cannabis Agri-park style development and opportunities for joint ventures, licensing and distribution partners. Its industry leading alliance partners include Eaton, Ledcor Group and Hamilton Utilities Corp.
Eaton is the second largest power management company in the world and promises to supply innovative and cost effective power solutions to meet TGOD’s growing demands. Construction management is supplied by Ledcor, Canada’s second largest multidisciplinary construction company and a pioneer in the Green Building Industry. An alliance with Hamilton Utilities Corp allows TGOD to reduce its power costs from $0.13 per kWh to less than $0.05 per kWh. Greenhouse design is provided by Larssen Greenhouse, whose 25-plus years of experience in building some of the most modern and sophisticated greenhouses in the industry will provide TGOD with state of the art, climate-controlled hybrid greenhouse solutions.
Canada is quickly becoming a hub for cannabis investors with over $1.3 billion raised by Canadian companies to date. There are 58 licensed producers to service a population of 36 million and only two organic producers. TGOD, which holds licenses in Ontario and Quebec, is strategically located in both provinces that together claim 22 million Canadians as residents. Another estimated 57 million people live next door in six U.S. bordering states.
The Canadian cannabis market currently has a massive supply demand gap, which makes TGOD’s expansion plans even more important to investors. These plans include a combined build-out capacity of 970,000 square feet, allowing TGOD to produce 116,000 kg annually of organic cannabis. Upon completion, Phase One in Hamilton, Ontario, which is fully funded, will provide 150,000 square feet of growing capacity capable of producing up to 14,000 kg of cannabis or $112 million in revenue at $8 a gram.
The company’s Quebec expansion will be constructed on a recently secured 75-acre property near Montreal. This new property has a planned expansion of 820,000 square feet capable of producing 102,000 kg of organic cannabis. The first phase of this expansion is underway and construction is expected to be completed by the end of 2018. Quebec’s first phase will consist of 220,000 square feet capable of producing 22,000 kg of cannabis. Two additional expansion phases will add 250,000 square feet (26,000 kg of cannabis) and 350,000 square feet (54,000 kg of cannabis). Power costs remain exceptionally low for both facilities with access to all other needed utilities available and close by.
TGOD also plans to gain a share of the burgeoning cannabis oils market which by Q1 2017 accounted for 49 percent of all cannabis sold in Canada under the ACMPR, up from only 27% in Q2 2016. TGOD has ordered a purpose-built extraction laboratory with an estimated commission in Q4 of 2017. This is a commercial-scale CO2 extraction unit capable of processing up to 12,000 kg of raw material per year and producing approximately $170 million worth of organic cannabis oils. Raw cannabis oil provides a significant downstream manufacturing opportunity into several potential recreational market verticals including edibles, beverages, topicals and concentrates.
Data from the Canadian ACMPR Market Trends report indicates a rising number of consumers will continue to seek out healthier, less conspicuous ways to consume cannabis, ensuring sales of organic cannabis oil products remain brisk. Organic cannabis products demand a significant premium compared to non-organic products and the demand keeps growing.
Plans to take the company public are underway with an initial public offering (IPO) slated for January 2018. In November, the company raised $13 million in equity financing and in March closed a $27 million non-brokered private placement. Another $20 million is currently being raised before the IPO in January, which will be utilized for expansion plans.
TGOD is uniquely positioned between the medical and recreational cannabis industry since Canada is scheduled to legalize cannabis for all adults in mid-2018. As of August 2017, TGOD has 2,400 shareholders. Established in 2012, TGOD’s motto, “Making Life Better,” can be seen in its strategic partnerships, top quality management team, and dedication to organic farming and principles.
To learn more about the company and how to invest, contact TGOD directly at email@example.com
The Green Organic Dutchman (OTC: TGODF), closed the day's trading session at $1.85, off by 3.65%, on 604,860 volume with 829 trades. The average volume for the last 3 months is 1,031,741 and the stock's 52-week low/high is $1.61/$7.89.
- The Green Organic Dutchman Adds Deep Medical and Pharmaceutical Experience to its Board of Directors with Appointment of Two New Directors
- Hemp/CBD Companies In U.S. and Canada Prepare For A Boon Poring Major Capital Into Grow Operations
- Canada Will Legalize Edibles by October 2019 - and the Market is Substantial
Cannabis Strategic Ventures, Inc. (NUGS)
Cannabis Strategic Ventures, Inc. (OTC: NUGS) today announces that it has submitted its application to uplist to the OTCQB® Venture Market. The uplisting criteria require the Company to file financial and other reports to the Securities & Exchange Commission in a timely manner in addition to undergoing an extensive verification and certification process. The Company believes it meets all of the requirements for a successful uplisting. Also today, the company was highlighted in an article from Financialnewsmedia.com examining how predictions for the worldwide growth of the cannabis industry show much optimism for both the recreational and medicinal cannabis segments. Worldwide projections see the North American market relying on recreational sales while the European markets will be in the medical arena.
Cannabis Strategic Ventures, Inc. (NUGS), headquartered in Los Angeles, California, is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. Through a selective portfolio of subsidiaries, Cannabis Strategic Ventures offers outsourced personnel solutions tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries and other cannabis marketplace participants. The company also pursues investment opportunities in the areas of real estate, cultivation, extraction, distribution, packaging, dispensary operations, and branded products within the cannabis space.
The legalization of adult-use sales in California is expected to create nearly 99,000 cannabis industry jobs in the state by 2021, representing about a third of all cannabis jobs nationwide, and 146,000 jobs overall when indirect and induced efforts are considered, according to Arcview Market Research. By 2021, direct cannabis industry employment will top 291,500 FTE jobs, with a total employment effect of nearly 414,000 FTEs across all legal cannabis states, according to the report.
Cannabis Strategic Ventures believes its staffing capabilities will be in a similar state of demand. The company in April 2018 completed a definitive agreement to acquire Worldwide Staffing Group, Inc., which booked approximately $1.5 million in revenues in 2017.
Worldwide will operate within Cannabis Strategic Ventures as an independent and separate wholly owned subsidiary providing strictly non-cannabis related employment and staffing services. As Worldwide continues to expand its operations in general clerical and administrative, marketing, accounting, and other verticals, Cannabis Strategic Ventures will leverage the subsidiary’s expertise to expand its business operations further into the cannabis staffing arena, with an emphasis on the California markets.
Cannabis Strategic Ventures’ BudHire™ subsidiary is an outsourced employment service specifically designed to meet the needs of growing cannabis-related business operations, utilizes a proven recruiting formula to match the most qualified candidates to a broad spectrum of cannabis-related jobs. Under the BudHire™ brand, Cannabis Strategic Ventures offers temporary, seasonal, permanent staffing solutions, as well as professional employment organization services and human resources consulting to the cannabis industry.
Cannabis Strategic Ventures portfolio also includes Pure Applied Sciences Inc. and its brand “PureOrganix™,” a line of high quality concentrate, organic and pure cannabis oils that conform with Current Good Manufacturing Practices (cGMP) and meet FDA guidelines for Active Pharmaceuticals Products (API). The acquisition includes all intellectual properties, including formulations and technologies, and related accessories of Pure Applied Sciences.
Cannabis Strategic Ventures Pure Applied Sciences subsidiary, has a cannabis concentrate extraction services agreement with CP Logistics LLC (“CPL”), a wholly owned U.S. subsidiary of Sunniva Inc. (CSE:SNN) (OTCQX:SNNVF). Under this agreement, CPL will perform white label services producing high quality, ultra-purified cannabis extracts out of its Sun-Oil Facility in Cathedral City, California, for Pure Applied Sciences under the Pure Organix brand name.
The management team at Cannabis Strategic Ventures believes there is incredible opportunity to carve-out and control specific industry niches, to create unique cannabis consumer branded products, and to expand into other sub-sectors of the cannabis marketplace.
Cannabis Strategic Ventures, Inc. (NUGS), closed the day's trading session at $1.73, up 1.17%, on 169,137 volume with 145 trades. The average volume for the last 3 months is 48,311 and the stock's 52-week low/high is $1.02/$5.94.
- Cannabis Strategic Ventures Submits Application to Uplist to OTCQB® Venture Market
- How Much of the U.S. Cannabis Growth Will Come From Recreational Use Market
- NetworkNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Eyes Opening for Specific Cannabis Industry Niches
Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8)
Kontrol Energy Corp. (CSE:KNR, FSE:1K8), ("Kontrol" or the "Company") is pleased to announce that it has launched a new IOT energy management hardware and software solution for the global commercial, multi-residential and hospitality real estate market.
Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8) specializes in the integration of smart energy technologies and solutions for North American commercial and industrial property owners and operators to help them benefit from energy cost savings and minimize greenhouse gas emissions. Kontrol is a leader in the energy efficiency sector through IoT, Cloud and SaaS technology and is ranked by Canadian Business and Maclean’s as the 7th fastest growing startup in 2018.
Kontrol’s leadership position is reshaping the way customers use, manage and strategically allocate energy resources to realize immediate energy savings by gaining more control over energy consumption and demand in real-time.
As the fastest growing global “fuel source,” energy efficiency is big business with industry analysts noting this multi-trillion-dollar market offers significant opportunities over the next five years. Established market segments include: energy retrofits ($71.4 billion); distributed generation ($179.9 billion); energy analytics ($33.5 billion); and greenhouse gas/carbon measurement, reduction ($1.2 trillion). Each $1 invested in energy efficiency displaces up to $3 of utility-scale transmission and distribution investment, according to the International Energy Agency.
Formed in 2015 by a group of energy veterans who recognized that the energy efficiency industry is one of the fastest growing fuel sources for the global economy, Kontrol is committed to enhancing and improving its customers sustainability objectives. In less than two years, Kontrol has grown its revenue run rate to $16 million from $1.8 million, delivering on stated goals and objectives as it seeks to continue this pattern through accretive acquisitions and the expansion of the company’s smart energy technologies.
Up to 50 percent of Kontrol’s overall revenues are recurring annually, and the company’s 2019 outlook includes strategic initiatives that will expand the company’s smart energy technologies to U.S. markets, bring additional accretive and strategic acquisitions, and accelerate recurring SaaS revenues.
Kontrol’s strategy of disciplined mergers and acquisitions includes the following highlights:
- Acquisition of Log-One Ltd.’s award-winning energy conservation technology, Energy Management System (“EMS”), an intelligent, occupancy-based heating and air-conditioning control system for commercial and multi-residential real estate. Rebranded as Kontrol EMS Technology, the company has added IoT and mobile application capabilities, creating a recurring revenue platform through a Software-as-a-Service (SaaS) platform.
- Acquisition of ORTECH Consulting Inc., an engineering consulting firm specializing in Greenhouse Gas (GHG) reporting, emission testing, air quality testing and renewable energy/power consulting.
- Acquisition of Efficiency Engineering Inc. (“EE Inc.”), which provides engineering services to industrial, municipal and commercial building owners across Canada. EE Inc. provides detailed energy efficiency analysis, energy audits, management of facility system solutions, electrical and mechanical design and energy conservation studies.
- Acquisition of MCW Dimax Ltd. (“MCX”), a firm specializing in solutions for the application of energy software to analyze the management of complex heating, ventilation and cooling systems for large residential, commercial, and mission critical real estate owners.
- Acquisition of CEM Specialties Inc. (“CEMSI”), a market leader in turn-key emission monitoring, equipment and solutions.
The company has also established entry into the North American cannabis market as a supplier of integrated energy efficiency solutions and technologies. Within this market, Kontrol is focused on assisting cannabis growers to reduce the cost of energy and support mission critical infrastructures. To date, Kontrol has secured two contracts to provide energy efficiency services with Licensed Producers in the Canadian cannabis sector.
The Kontrol Energy group of companies is currently saving its customers more than 40 million kilowatt hours of electricity per annum and providing a corresponding reduction in GHG emissions.
Kontrol’s management team includes CEO Paul Ghezzi, a leader in clean tech, renewable energy development, solar project financing and distributed generation. Ghezzi has global experience in power generation projects under Feed-in Tariff programs and Power Purchase Agreement programs for both commercial and utility-scale projects. COO Kristian Lavereau has more than 25 years of experience in the IT solutions (analytics and mobile computing), energy optimization and efficiency (intelligent control systems, solar PV, lighting). Claudio Del Vasto, CPA, CA | CFO, is a senior finance executive with an extensive background in corporate finance, strategy and business development.
Kontrol Energy Corp. (CSE: KNR), closed the day's trading session at $0.65, off by 4.41%, on 18,500 volume with 5 trades. The average volume for the last 3 months is 20,400 and the stock's 52-week low/high is $0.46/$1.58.
- Kontrol Energy Introduces SmartSuite(R) Energy Management Technology for Global Commercial, Multi-Residential and Hospitality Real Estate Market
- Kontrol Energy Corp.’s (CSE: KNR) (FSE: 1K8) Smart Energy Solutions Could Cut Cannabis Cultivation Costs
- NetworkNewsBreaks – Kontrol Energy Corp. (CSE: KNR) (FSE: 1K8) Looking Forward to a Bright New Year
First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF)
First Cobalt Corp. (TSX-V: FCC; ASX: FCC; OTCQX: FTSSF) (the "Company") is pleased to announce it has engaged Brown and Caldwell at the Iron Creek Project to provide guidance on permitting and to develop an environmental baseline study strategy.
First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF), with headquarters in Canada, is the largest land owner in the Cobalt Camp in Ontario with control of over 10,000 hectares (nearly 25,000 acres) of prospective land and 50 historic cobalt/silver mines. The company’s assets include a mill and the only permitted cobalt extraction refinery in North America capable of producing battery material, providing an integrated solution for cobalt projects. First Cobalt began drilling in the historic Cobalt Camp in 2017 and seeks to build shareholder value through new discovery and growth opportunities.
First Cobalt’s 2018 $C7 million drilling program, which includes testing different styles of mineralized areas throughout the Cobalt Camp in more than 10 past-producing mines known to contain cobalt, is a significant expansion over its 2017 exploration activities. The company received positive test drill results from the Bellellen mine location, with early results confirming the presence of high-grade cobalt and nickel, prompting First Cobalt to increase its drilling program at that site. A prospecting sampling program of existing muckpiles around the camp’s historic mines, trenches, pits and surrounding bedrock could provide an early production scenario.
First Cobalt Corp. is moving quickly to leverage its potential against an economic background that estimates global consumption for refined cobalt is set to grow at an average rate of approximately 5 percent per annum for the next 10 years. The electric vehicle market, in particular, is driving this sector since more than 50 percent of the world’s current production of cobalt is used in the manufacture of rechargeable lithium-ion batteries. The global lithium-ion battery market, as estimated by Zion Market Research, indicates the value at around USD $31 billion in 2016 and is expected to generate revenue of nearly USD $68 billion by end of 2022, growing at a compound annual growth rate of slightly above 17 percent.
First Cobalt is embracing innovation in the mining sector, utilizing a digital compilation of 100-plus years of mining and geological data spanning the historically prolific Cobalt Mining Camp’s lifespan. First Cobalt’s management team is also assessing the ability of artificial intelligence to accelerate the discovery cycle. As a member of the Mineral Exploration Research Centre (MERC) and Metal Earth Project, First Cobalt conducts regional geophysical surveys for geological interpretation of structures controlling cobalt-silver mineralization.
The company’s clear pathway to production and cash flow generation includes being one of only four fully permitted cobalt extraction refineries in Canada with significant material and processing infrastructure on site. With the price of cobalt increasing significantly and its importance in the growing battery market underpinning a strong long-term demand forecast, First Cobalt Corp. and its mining interests are primed for success.
First Cobalt Corp. President and CEO Trent Mell, a mining executive and capital markets professional with extensive international transactional experience, is joined by a team of reputable and seasoned deal-makers, mine builders and mine operators with decades of global experience in exploration, business development, geoscience, engineering and finance.
First Cobalt Corp. (FTSSF), closed the day's trading session at $0.1338, even for the day, on 53,652 volume with 25 trades. The average volume for the last 3 months is 191,505 and the stock's 52-week low/high is $0.1143/$1.21.
- First Cobalt Begins Permitting and Environmental Programs at Iron Creek
- NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Aims to Build a North American Cobalt Supply Chain
- First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Aims to Capitalize on Forecast Cobalt Demand Increase in 2019
SinglePoint, Inc. (SING)
Technology and investment company SinglePoint (OTCQB: SING) this morning announced its investment in TorusMed Inc. to develop cannabidiol (“CBD”) cell cultures from industrial hemp. To view the full press release, visit: http://cnw.fm/hRc4w.
SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.
SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.
SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:
- A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
- A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
- A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
- Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
- Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
- Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.
SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.
Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.
SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.
SinglePoint, Inc. (SING), closed the day's trading session at $0.0235, off by 0.68%, on 7,844,174 volume with 299 trades. The average volume for the last 3 months is 6,003,293 and the stock's 52-week low/high is $0.0106/$0.09956.
- CannabisNewsBreaks – SinglePoint, Inc. (SING) Invests in TorusMed Inc. for Lab-Based Development of CBD Cell Cultures
- SinglePoint Invests in TorusMed Inc. to Develop CBD Cell Cultures through Photobioreactors
- Legislative Changes in the US Provide SinglePoint, Inc. (SING) with Rapid Growth Opportunities in 2019 and Beyond
The QualityStocks Numbers Report
QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.
The QualityStocks Sponsored News
- Aziza Project LLC, Investing in Operations in the Southern Africa Region
- BriaCell Therapeutics Corp. (OTC: BCTXF) (TSX.V: BCT) Advances Novel Formulation of Drug Candidate in Battle against Advanced Breast Cancer
- Cannabis Strategic Ventures, Inc. (NUGS) Submits Application to Uplist to OTCQB® Venture Market
- Canopy Rivers Inc. (TSXV: RIV) Announces Investment in Technology Driven Data Company Headset
- ChineseInvestors.com (CIIX) 420 with CNW – Want to Make Money in 2019? Think About These 3 Cannabis Trends
- Choom Holdings Inc. (CSE: CHOO) (OTC: CHOOF) 420 with CNW – Want to Make Money in 2019? Think About These 3 Cannabis Trends
- Consorteum Holdings, Inc. (CSRH) Universal Mobile Interface Platform Enables Communication Between Different Platforms and Devices
- Cyberfort Software, Inc. (CYBF) Vivio App Fends Off Potential Cyber Security Threats
- CytoDyn Inc. (CYDY) to Deliver Presentation at Biotech Showcase Conference
- DPW Holdings, Inc. (NYSE American: DPW) Subsidiaries Receive Debt Financing to Decrease Defense Sector Order Backlog
- Earth Science Tech, Inc. (ETST) Announces Strategic Partnerships to Market Hygee™ and Address Global Epidemic
- FinCanna Capital Corp. (CSE: CALI) (OTC: FNNZF) Increases Convertible Debenture Financing to $2.0 Million
- First Cobalt Corp. (TSX.V: FCC) (OTC: FTSSF) Begins Permitting and Environmental Programs at Iron Creek
- Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Eye-Net Mobile Successfully Completes Initial Integration with the Assistance of a Leading Israeli Cellular Provider
- Generation Alpha, Inc. (GNAL) 420 with CNW – Mexico to Consult Other Countries on Cannabis Legalization, Minister Reveals
- Global Payout, Inc. (GOHE) and MTrac Provide Shareholder Update, Look Back at Accomplishments and Forward to Extraordinary 2019
- Golden Developing Solutions, Inc. (DVLP) 420 with CNW – Arkansas Delays Issuing Medical Cannabis Cards
- Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) US President, Producers Envision ‘Green Acres’ with Signing of Historic Hemp-Legalizing Farm Bill
- Green Hygienics Holdings Inc. (GRYN) 420 with CNW – Arkansas Delays Issuing Medical Cannabis Cards
- GTX Corp (GTXO) Secures a $500,000 Revolving Line of Credit for Product Financing and Signs up Two New Distributors
- Icon Exploration Inc. (TSX.V: IEX.H) Building Presence in Booming Cannabis Space
- Kontrol Energy Corp. (CSE: KNR) (OTC: OTSHF) (FSE: 1K8) Introduces SmartSuite(R) Energy Management Technology for Global Commercial, Multi-Residential and Hospitality Real Estate Market
- Lexaria Bioscience Corp. (CSE: LXX)(OTC: LXRP) Proprietary Technology Transforms the Way Molecules Enter the Body
- Lithium Chile Inc. (TSX.V: LITH) (OTC: LTMCF) Enhances Technical Team and Board of Directors; Appoints Leading Lithium Expert, and Grants Stock Options
- Marijuana Company of America Inc. (MCOA) Announces Filing of Registration Statement on Form S-1 to Receive up to $10M to Fund Expansion
- Medical Cannabis Payment Solutions (REFG) Ideally Positioned as Federal Hemp Laws Transform
- Net Element, Inc. (NASDAQ: NETE) Asset Acquisitions Grant New Potential to Payment Technology Developer
- Pacific Rim Cobalt Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Provides Update to Shareholders on 2018 Progress
- Pacific Software, Inc. (PFSF) Issues Update on Launch of E-Commerce Trade Platform
- Phivida Holdings Inc. (CSE: VIDA) (OTC: PHVAF) Applauds the Passing of the 2018 Farm Bill; Appoints New Member to Board of Directors
- Plus Products Inc. (CSE: PLUS) Solidifies Leading Edibles Position in California with Acquisition of Cannabis-Infused Baked Goods Manufacturer
- Pressure BioSciences Inc. (PBIO) Announces Commercial Launch of its Unique Biopharmaceuticals Contract Services Business
- QMC Quantum Minerals Corp. (OTC: QMCQF) (TSX.V: QMC) (FSE: 3LQ) Existing Infrastructure at Irgon Mine Project to Drive Speedy Development
- Redfund Capital Corp (CSE: LOAN) (Frankfurt: O3X4) (OTC: PNNRF) Focuses on Medical Cannabis, Hemp and CBD-related Companies as Export Laws Begin to Shift in Israel
- Sharing Services, Inc. (SHRV) Revitalizing the Direct Sales Industry via the Blue Ocean Strategy
- SinglePoint, Inc. (SING) Invests in TorusMed Inc. for Lab-Based Development of CBD Cell Cultures
- Spectrum Global Solutions, Inc. (SGSI) Revenues Tracking Over $33M Annually Attributed to Acquisition, Operations
- Sproutly Canada, Inc. (OTC: SRUTF) (CSE: SPR) (FRA: 38G) Building Cannabis-Infused Beverage Solutions with Leadership Depth
- Standard Lithium Ltd. (TSX.V: SLL) (FRA: S5L) (OTC: STLHF) Makes First Pilot-Scale High Purity Lithium Carbonate and Commissions Crystallisation Pilot Prototype
- Sugarmade, Inc. (SGMD) Stands Firm in its Commitment to Supply the Legal Cannabis Cultivation Industry
- Sunniva, Inc. (CSE: SNN) (OTC: SNNVF) Secures Over $2.4M in Initial Cannabis Product Sales in California
- Supreme Cannabis Company Inc. (TSX.V: FIRE) (OTC: SPRWF) Inks Consulting Agreement with Khalifa Kush Enterprises
- Teewinot Life Sciences Produces Cannabinoids through Patent-protected CANNSYNTHESIS Technology - QualityStocksNewsBreaks
- The Flowr Corp. (TSX.V: FLWR) Identifies Acquisition of Stake in Holigen as ‘Transformative Transaction’
- The Green Organic Dutchman (TSX: TGOD) (OTC: TGODF) Adds Deep Medical and Pharmaceutical Experience to its Board of Directors with Appointment of Two New Directors
- Therma Bright Inc. (TSX.V: THRM) (OTC: THRBF) Sees Opportunity in Applying Novel Skin Remedies to Health Concerns
- TransCanna™ Set to Get Marijuana Moving Across California ‘Pot Desert’ Landscape
- United Battery Metals Corp. (CSE: UBM) (OTC: UBMCF) (FWB: 0UL) Retracts Technical Disclosures
- Victory Marine Holdings Corp. (VMHG) Aims to Offer Tailored Customer Care Following Sales
- VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) Announces Appointment of Dr. Richa Love as Chief Medical Officer
- Youngevity International, Inc. (NASDAQ: YGYI) CLR Roasters Ships First 3.8 Million Pounds of Green Coffee Under its 5-Year Estimated $250 Million Green Coffee Contract
- Zenergy Brands, Inc. (ZNGY) Utilizing REP Division to Promote its Zero Cost Program
The QualityStocks DailyNetwork Sponsors
About The QualityStocks Daily
The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.
Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.
"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.